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CHARACTERIZATION OF TRANSFER OF THE MOBILE GENOMIC ISLAND  
ENCODING METHICILLIN RESISTANCE AMONG STAPHYLOCOCCI 
 
By Melissa Darlene Ray, Ph.D.  
 
A dissertation submitted in partial fulfillment of the requirements for the degree of 
Doctor of Philosophy at Virginia Commonwealth University  
 
Virginia Commonwealth University, 2015  
 
Director: Gordon L. Archer, MD 
Senior Associate Dean for Research and Research Training 
Professor, Departments of Internal Medicine and Microbiology and Immunology 
 
 
The gene encoding methicillin resistance in Staphylococcus aureus (MRSA) is carried in 
the chromosome on a large genomic island called SCCmec and is always inserted at the 
att site within orfX. SCCmec has been designated a mobile genetic element but a 
mechanism by which it moves among different strains and species of staphylococci has 
never been demonstrated. This work shows that bacteriophage 80α is capable of 
transducing SCCmec into a recipient cell, after which it can integrate into the bacterial 
chromosome via homologous recombination. More importantly, this work characterizes a 
conjugative mechanism of SCCmec transfer.  Results demonstrate the capture of a 30.8 
kb SCCmec element on a conjugative plasmid for the first time, its transfer into both S. 
aureus and S. epidermidis recipients, and its excision from the plasmid with insertion in 
the orfX att site in recipients. The element was integrated into the plasmid by 
recombination between IS elements invariably present on all SCCmec types and 
pGO1/pSK41-like conjugative plasmids.  These data explain the movement of SCCmec 
from reservoirs in commensal coagulase-negative staphylococci into different 
Staphylococcus aureus lineages using a ubiquitous conjugative plasmid that can transfer 
among staphylococci of different species and, thus, describes a mechanism for the 
environmental dissemination of methicillin resistance in nature. 
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CHAPTER 1 
 
 
Introduction 
 
 
 
 
Staphylococci and Methicillin-Resistant Staphylococcus aureus 
 
 
 The genus Staphylococcus is comprised of more than forty different species of 
Gram-positive bacteria, including the coagulase-negative staphylococci (CoNS) such as 
Staphylococcus epidermidis and Staphylococcus haemolyticus and the coagulase-positive 
staphylococci such as Staphylococcus pseudintermedius and Staphylococcus aureus.  S. 
aureus was first discovered from a surgical abscess in 1880 by Sir Alexander Ogston in 
Scotland and has become the most researched member of the staphylococci because of its 
ubiquitous role in disease (1).  Staphylococci are a part of the normal flora, and the major 
site of S. aureus colonization in humans and animals is the anterior nares.  Individuals are 
categorized as persistent carriers, intermittent carries, or noncarriers of S. aureus (2).  The 
bacterium spreads through skin-to-skin contact with an infected person and also by 
contact with objects such as athletic equipment, towels, needles, and razors used by an 
infected person.   
S. aureus is an opportunistic pathogen, and infections can occur when the skin or 
mucosal barriers have been breached. Infections range from minor, generally self-limiting 
skin complications such as impetigo, furuncles, and boils to severe life-threatening 
clinical manifestations, including but not limited to, bacteremia, osteomyelitis, 
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pneumonia, necrotizing fasciitis, and endocarditis (3).  S. aureus is the most common 
cause of nosocomial infections and is also capable of causing a wide range of diseases 
within the community (4).  This organism causes severe diseases due to its ability to 
express a plethora of virulence factors (3).  Noteworthy virulence factors of most disease-
associated strains include Panton-Valentine leukocidin (PVL), alpha-toxin, phenol-
soluble modulins (PSMs), and superantigens.  PVL is a bi-component exotoxin that is 
able to form pores in the membranes of neutrophils, the first line of host defense against 
infection, ultimately leading to their lysis (5, 6).  Alpha-toxin is a pore-forming toxin 
present in many S. aureus strains that does not lyse neutrophils but instead lyses other 
immune cells such as macrophages and lymphocytes (7, 8).  PSMs are a class of secreted 
peptides that are able to recruit, activate, and lyse neutrophils (9, 10).  Many strains of S. 
aureus also produce superantigens that non-specifically activate T-cells, resulting in 
massive cytokine release leading to serious toxinoses such as toxic shock syndrome (11, 
12).  In addition to a wide array of virulence factors, infections are further complicated by 
the ability of S. aureus to develop resistance to multiple antimicrobial agents. The 
increase of antibiotic resistant strains, especially methicillin-resistant S. aureus (MRSA), 
has further complicated therapeutic approaches.  
The first strain of MRSA was isolated in 1961 from a European hospital just two 
years after the introduction of methicillin and soon after spread to other countries, 
becoming a significant concern in the United States in the 1970s (13, 14).  Currently, in 
the United States MRSA, strains account for more than 50% of all S. aureus isolates 
causing clinical disease (15).  Healthcare-associated MRSA (HA-MRSA) is mainly 
associated with bacteremia and other invasive infections in hospitalized patients who 
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often have other illnesses (3).  MRSA infections account for prolonged hospital stays, 
increased costs in the health care system, and the highest annual death rate for any 
infectious species (16, 17).  Initially, MRSA strains were only problematic for 
hospitalized patients and those with chronic illnesses, but in the 1990s MRSA became 
more prevalent in the community - otherwise known as community-associated MRSA 
(CA-MRSA).  These strains usually cause skin and soft tissue infections (SSTIs) in 
otherwise healthy people in the community, including children, professional athletes, 
soldiers, incarcerated individuals, and parenteral drug users (18-21).  Today CA-MRSA 
strains, in particular USA300, are the frequent cause of bacterial infections in individuals 
without health care exposure (3).  These strains ultimately led to a rise of life-threatening 
CA-MRSA infections such as community-acquired pneumonia (22).   During the past 
two decades, MRSA and methicillin-resistant CoNS have spread throughout the world 
(23).  Treatment is difficult and cumbersome because MRSA strains are resistant to β-
lactam antibiotics.  
 
Resistance to β-lactam antibiotics 
 
Soon after the application of successful antibiotics to treat infectious diseases, 
there was an immediate emergence of resistant bacteria.  This increased resistance is due 
to evolution and selective pressure of bacterial strategies to combat the actions of 
antibiotics and is an aftereffect of the extensive use of antibiotics in medicine and 
agriculture.  Bacterial strategies to combat antibiotics include modifying and inactivating 
the drug, eliminating the drug, and/or altering the target of the antibiotic.  S. aureus has 
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developed resistance to every major class of antibiotics, including aminoglycosides, 
macrolides, tetracyclines, fluoroquinolones, oxazolidinones, mupirocin, glycopeptides, 
and β-lactams (24).   
Specifically, β-lactams are bactericidal, cell wall-active antibiotics that inhibit the 
transpeptidation step of peptidoglycan synthesis.  Both sensitive and resistant S. aureus 
strains produce four transpeptidases, also known as penicillin-binding proteins (PBPs) 
(25).  β-lactams mimic the natural substrate of PBPs, which is the terminal D-alanine-D-
alanine of the peptidoglycan, and covalently bind to and inhibit the activity of the PBPs 
which prevents cross-linking of the cell wall resulting in cell death due to osmotic lysis 
(26, 27).   
Resistance to β-lactams in MRSA can be two-fold.  β-lactams such as penicillin  
are inactivated by β-lactamases, whereas β-lactamase-resistant antibiotics such as 
methicillin, oxacillin, and nafacillin are ineffective because the bacterium produces an 
altered target PBP.  β-lactamases bind to and cleave the β-lactam rendering it inactive 
(28).  The gene encoding β-lactamase (blaZ) in S. aureus is usually located on a plasmid 
and is regulated by two divergently transcribed genes, blaI and blaR1, encoding a 
transcriptional repressor and a membrane spanning signal transducer, respectively (29, 
30).  In the presence of a β-lactam antibiotic, BlaR1 autocleaves and signals for the 
cleavage of the BlaI repressor, resulting in derepression of blaZ transcription and 
production of β-lactamase (31). To overcome enzymatic inactivation, β-lactamase-
resistant antibiotics, such as methicillin, were introduced.  However, methicillin resistant 
strains quickly emerged due to the acquisition of the mecA gene (32, 33).     
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mecA- an alternative penicillin binding protein (PBP2a) 
 
 The mecA gene encodes an alternate penicillin-binding protein (PBP2a) that has a 
low affinity for β-lactam antibiotics. PBP2a is an inducible 76kDa high molecular weight 
class B PBP (37).  The penicillin-binding motifs are the same in the high affinity PBPs as 
in PBP2a, so the structural basis for the low affinity of β-lactam antibiotic binding to 
PBP2a is not well understood (38).  Nonetheless, PBP2a substitutes for the necessary 
functions of high-affinity PBPs that are blocked in the presence of β-lactam antibiotic so 
that cell wall synthesis is able to occur at concentrations of antibiotic that would 
otherwise be lethal.   
 Regulation of mecA is similar to that of blaZ, the staphylococcal β-lactamase. The 
regulatory genes of mecA are mecI and mecR1, and they encode for a transcriptional 
repressor and a membrane signal transducer, respectively, which are similar in structure 
and function to blaI and blaR1 of blaZ, as mentioned previously (39-41).  Specifically, 
MecI binds to the promoter region of mecA and represses its transcription.  Derepression 
is achieved through MecI cleavage once the signal transducer, MecR1, has been activated 
in the presence of a β-lactam such as methicillin (42, 43).  Intact and fully functional mec 
regulatory elements strongly repress PBP2a production (44, 45).  Upon analysis, it was 
found that the majority of clinical isolates, an example being the S. aureus strain COL, 
have deletions in mecR1 resulting in constitutive PBP2a production (46-48).  
Interestingly, both MecI and BlaI are able to bind to the promoter and repress 
transcription of mecA (49).  Therefore, in strains constitutively expressing mecA, if the 
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plasmid-encoded β-lactamase and its regulatory genes are present then mecA transcription 
and PBP2a production is co-regulated by the β-lactamase elements and expression is 
controlled.   
 An important characteristic of methicillin resistance is the variation in its 
phenotypic expression.   MRSA strains that contain mecA and produce PBP2a can either 
be heterotypically or homotypically resistant to β-lactam antibiotics, and the level of 
resistance can vary according to culture conditions and the β-lactam used (27).  The 
majority of MRSA strains are heterotypically resistant to methicillin, meaning that nearly 
all of the cells in heterotypic strains (99.9% or more) are susceptible to low 
concentrations of β-lactam antibiotics (1-5µg/ml methicillin) with only a small population 
of the cells (1 in 106) growing at methicillin concentrations of 50µg/ml or higher.  This is 
in contrast to the homotypic resistant phenotype where the entire population expresses 
high level resistance and can grow at methicillin concentrations of 50-100µg/ml (50).  
While the majority of MRSA strains are heterogeneous, there are clinical isolates, such as 
S. aureus COL, and laboratory-derived mutants, that are homogeneous.  In some cases it 
is possible to select a homogeneous population from the heterogeneous population by 
passage of the strain in the presence of a β-lactam.  This conversion to homotypic 
resistance is essentially due to selection of a highly resistant mutant population of cells 
that, importantly, are also stable when passaged in antibiotic-free media (51).  Overall, 
heterogeneity and the other factors involved in this phenotypic characteristic of 
methicillin resistance are important yet not fully understood. 
 Of recent importance, MRSA isolates were detected that were phenotypically 
resistant to methicillin yet tested negative for mecA.  This was first discovered in a bovine 
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MRSA isolate, S. aureus LGA251, and upon further analysis a divergent mecA homolog 
was identified (52).   Since then, this homolog has been found in animal isolates from a 
domestic dog, brown rats, a rabbit, sheep, and even in human mecA-negative MRSA 
isolates from Scotland, England, and Denmark (52, 53).  This homolog was eventually 
named mecC and is 70% identical to S. aureus mecA (52).  Harrison et al. have recently 
reported a new allotype of mecC in Staphylococcus xylosus named mecC1 that shares 
93.5% nucleotide identity to mecC in S. aureus LGA251 (54).   Regardless of the type, 
the mec gene is always found in the same region of the staphylococcal chromosome and 
is associated with approximately 30-50 kb of extra chromosomal deoxyribonucleic acid 
(DNA) that is not found in susceptible strains.  This region is known as staphylococcal 
cassette chromosome mec or SCCmec.  
 
Staphylococcal cassette chromosome mec, SCCmec 
 
 The SCCmec element carries the mecA gene, and, therefore, is found in all 
MRSA. SCCmec elements are a unique class of staphylococcal mobile genetic elements, 
and the emergence of different MRSA lineages is due to the acquisition and insertion of 
the SCCmec element into the chromosome of susceptible strains.  The first SCCmec 
element was identified in the Japanese S. aureus strain N315.  Soon after, two additional 
SCCmec elements from different MRSA strains were discovered.  Based on structural 
analysis, these elements were classified as SCCmec types I, II, and III (55, 56).  Shortly 
after, many other types of SCCmec were discovered, such as types IV through XI, as well 
as other variants of already reported SCCmec types ranging in size from 21 kb to 67 kb 
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(57-65). One specific variant that has had tremendous epidemiological success is 
SCCmec type IVa of USA300 CA-MRSA.  This variant has the arginine catabolic mobile 
element (ACME) located downstream of SCCmec, forming the SCCmec-ACME 
composite island, and the presence of the arginine deiminase system encoded on ACME 
enhances the ability of USA300 CA-MRSA to survive within the host and likely 
contributing to its epidemiological success (66, 67). 
 With an increasing number of SCCmec variants, types, subtypes, and pseudo-
SCCmec elements described in the literature, the International Working Group on 
Classification of Staphylococcal Cassette Chromosome elements (IWG-SCC) was 
established in 2009 to define a uniform nomenclature system and establish guidelines for 
identifying new SCCmec elements (68).  Different SCCmec elements share three 
common features, as follows: i) a mec complex, consisting of the mec operon ii) a ccr 
gene complex, composed of cassette chromosome recombinase (ccr) genes and iii) 
joining (J) regions bordering the mec and ccr complexes (65, 68).  SCCmec elements are 
classified into types and subtypes based on the structural organization and genetic content 
of these features.  Types are defined by the combination of the type of ccr complex and 
the class of mec gene complex.  Subtypes are variations in the J regions with the same ccr 
and mec gene complexes.  SCCmec elements also frequently include integrated insertion 
sequences, plasmids, and transposons that often encode additional resistance factors. The 
molecular typing of MRSA is further characterized by pulsed-field gel electrophoresis 
(PFGE), multilocus sequence typing (MLST), spa typing, and the designated SCCmec 
type in order to define a MRSA clone as it relates to the genotype of the methicillin-
sensitive S. aureus (MSSA) strain in which it was integrated.   
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 Despite numerous differences in typing, all SCCmec elements have conserved and 
defining features.  For instance, SCCmec elements always integrate into the 
staphylococcal chromosome at a specific site designated attB within the 3’ end of the 
orfX gene that encodes a ribosomal methyltransferase (69). The integrated element is 
always flanked by direct and inverted repeat sequences (DR and IR respectively).  All 
elements also harbor the mec complex that consists of mecA, mecI, and mecR1 as well as 
the ccr genes that encode serine recombinases that mediate site-specific integration and 
excision of the element.  In addition, SCCmec elements possess an extremely common 
insertion sequence (IS), IS431, within its mec complex that is also frequently found on 
many staphylococcal plasmids (64, 68).  Based on these characteristics and the fact that 
mecA is widely distributed among multiple staphylococcal species, SCCmec is 
considered a mobile genetic element that can be transferred among staphylococci.   
  
Excision of SCCmec 
 
 Excision is the first step in understanding how SCCmec is transferred among 
staphylococci.  Site-specific excision and integration of SCCmec is catalyzed by the Ccr 
recombinases encoded within the element, which belong to the large serine family of site-
specific DNA recombinases named after the large C-terminal domain and the active-site 
serine nucleophile (70, 71).   This family includes many bacteriophage integrases, such as 
those of phiC31, Bxb1, TP901-1, and R4 (72-77), as well as the transposases TndX and 
TnpX from Tn5397 and Tn4451 (78, 79).  The bacteriophage integrases usually mediate 
integration reactions without the addition of other proteins, but the excision reaction 
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requires an additional phage encoded directionality protein (74, 80-82).  In contrast, the 
large serine transposases TndX and TnpX catalyze both reactions without additional 
factors (78, 79).  For SCCmec, the Ccr proteins alone, without the aid of other 
staphylococcal proteins, are all that is required for the recombination reactions, and thus 
they more closely resemble the large serine transposases TnpX or TndX. 
 SCCmec integration involves a fifteen base pair (bp) core attachment (att) site 
referred to as attB, located within the 3’ end of orfX, which recombines with the similar 
att site, attS, on the circular SCCmec element.  As a result of the recombination reaction, 
SCCmec integrates into the chromosome, with two direct repeats designated attR and attL 
flanking the element on the left and right end respectively.  Ccr recombinases also act on 
attR and attL to excise the element.  When SCCmec excises it forms a non-replicating 
circular intermediate harboring the reconstituted attS site, and leaving the reconstituted 
attB site within orfX on the chromosome.  Jansen et al. discovered an additional att 
sequence (attR2) within SCCmec located 84bp downstream of the previously identified 
att sequence (attR1) at the 3’ end of orfX (83). 
 There are three phylogenetically distinct ccr genes: ccrA, ccrB, and ccrC.  Certain 
SCCmec elements have the ccrA and ccrB genes (ccrAB), contained within the same 
transcriptional unit, whereas other elements, namely SCCmec type V, only have ccrC 
(68).  Secondary structural analysis revealed that CcrB contains a predicted DNA binding 
motif and further biological analyses confirmed that CcrB binds directly to the core att 
site sequence.  While CcrA does not bind DNA, it was shown to interact with CcrB to aid 
in excision and integration.  Excision was shown to occur at both attR1 and attR2 sites 
with both CcrA and CcrB, but CcrB alone could mediate excision at the internal attR2 
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site without the help of CcrA (71).  Both CcrA and CcrB are required for SCCmec 
integration (84), and CcrC alone mediates excision and integration of SCCmec type V 
(58). Several allotypes have been described for ccrA and ccrB and these are used to 
classify the SCCmec types as mentioned previously.  However, only one allotype was 
found for the ccrC gene (68). Even though there is significant variation at the amino acid 
level for the CcrA and CcrB proteins, CcrA and CcrB recombinases from each type can 
excise the SCCmec of various types (85). In contrast, CcrC can only excise SCCmec type 
V (58). The promiscuity of CcrA and CcrB proteins suggests that other mobile elements 
with an att site sequence similar to SCCmec could potentially be inserted into the 
staphylococcal chromosome at attL or attR via Ccr-mediated recombination.  An example 
is the SCCmec-ACME composite island mentioned previously which can excise via 
CcrAB (66, 83).  However, some specificity for Ccr-mediated excision and integration is 
imposed by sequences flanking the att sites that differ among MRSA strains and are 
important in the recognition, binding, and recombination mediated by CcrAB (86, 87).  
 It has been noted that there is a critical stoichiometry between CcrA and CcrB that 
determines optimal activity for integration and excision, and that ccrAB overexpression 
from a multicopy plasmid shifts the predominant recombination activity from integration 
to excision resulting in conversion of MRSA into MSSA (71, 84, 85).  On the other hand, 
spontaneous excision of SCCmec has been observed on several occasions in vivo and in 
vitro yet takes place at a low frequency (56, 88-91).  Stojanov et al. found the 
spontaneous excision frequency of SCCmec to be 10-5 to 10-6 (166).  
Spontaneous excision occurs at an extremely low frequency, and few studies have 
investigated what regulates ccrAB expression.  β-galactosidase assays and quantitative 
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polymerase chain reaction (qPCR) studies have shown that β-lactams and vancomycin 
increased ccrAB transcription in MRSA strains N315 and MW2 (92).  Stojanov et al. also 
sought to answer whether the ccrAB promoter region could carry specific operators for 
alternative sigma factors, as recently shown in certain S. aureus prophages (93), but no 
similar regions were found (94) Another hypthesis for ccrAB regulation was based on the 
well-described regulatory excision system of conjugative islands of Bacillus subtilis, in 
which the excisionase gene is regulated by a typical repressor and anti-repressor system 
(95).  Stojanov et al. searched for a related system in staphylococcal strains and, while 
one was found in S. haemolyticus, none were found in S. aureus for ccrAB (94). 
Therefore, ccrAB regulatory elements, if any, have yet to be identified.  
 In an important study, Stojanov et al. used promoter-green fluorescent protein 
(GFP) fusions to measure the expression of ccrAB genes in individual cells of various 
strains of MRSA carrying different types of SCCmec elements.  They found that ccrAB 
promoter activity was not present simultaneously in all the cells of a culture but only in a 
small fraction of the entire population (94). This stochastic gene expression has been 
referred to as “bistability” and has been described in the transfer of other genomic 
islands.  Specifically, bistability in clonal bacterial populations is well known from 
competence development and sporulation in B. subtilis (96, 97).  Minoia et al. described 
the role of bistability as it relates to horizontal gene transfer (HGT) for the first time with 
the integrative and conjugative element (ICE), ICEclc, in Pseudomonas knackmussi (98, 
99).  In this scenario, cells seem to express phenotypic variation into transfer-proficient 
and transfer-silent subpopulations, and results suggest that the bistable switch is 
stochastic and can be further attuned by external conditions.  The authors note that 
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because excision is a requirement for ICEclc transfer, the stochastic decision for excision 
forms a key event in transfer control.  However, the low frequency of the bistable 
population makes it a difficult mechanism to study (98).  In contrast to ICEclc, the 
activity of the ccrAB promoters tested by Stojanov et al. were influenced by determinants 
elsewhere on the chromosome and not within the SCCmec element itself, as deletion of 
the element did not alter promoter activity (94).  In S. aureus, specifically, bistability 
rates increased under various stressful environmental conditions such as high temperature 
or treatment with a mutagen such as mitomycin C, and results showed that ccrAB activity 
and bistability depended on the microbial background (94).  The observations were 
similar to the bistability of the ICEclc-related transfer, and optimal settings imply that 
only a few cells in the MRSA population lose their advantageous SCCmec element to 
become methicillin susceptible and thus sacrifice themselves in order to transfer SCCmec 
into new recipient strains.  
 
Horizontal gene transfer in S. aureus 
 
 Horizontal gene transfer is the exchange of DNA between two cells and is 
important for bacterial evolution.  Genomic islands (GEIs) are mobile DNA elements 
able to undergo HGT by excision, transfer, and integration into a new cell.  They are 
grouped with other mobile DNA elements such as conjugative transposons and 
integrative and conjugative elements (ICEs) (100-102).  GEIs typically carry genes that 
provide bacteria with advantageous characteristics such as virulence factors, antibiotic 
resistance mechanisms, and toxin production to enhance bacterial adaptation and survival 
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in otherwise adverse conditions (103-106).  There are many well-described bacterial 
GEIs, including SXT of Vibrio cholerae (105), ICEHin1056 of Haemophilus influenza 
(106), staphylococcal pathogenicity islands (SaPIs) from S. aureus (103), ICEclc from 
Pseudomonas knackmussi (99), PAPI-1 from Pseudomonas aeruginosa (107), and 
Tn1546 from Enterococcus faecium (108).  Based on similarities with these systems and 
SCCmec characteristics discussed previously (i.e., presence of an antibiotic marker, 
possessing serine recombinases for excision and integration, integration at a specific site 
in the chromosome, presence of direct repeats at both ends of the element, and carriage of 
IS431), SCCmec is considered a mobile element.   
 While SCCmec is believed to be a mobile element, the origins of mecA are still 
unclear.  What is known is that SCCmec elements are not restricted to S. aureus, and in 
fact the identical SCCmec element is found in S. epidermidis RP62A as in S. aureus 
N315.  SCCmec elements are also commonly found in other staphylococci, such as S. 
haemolyticus and S. pseudintermedius (109, 110).  These observations and other data 
suggest that CoNS may be the reservoir of SCCmec for S. aureus (34, 111).  
Interestingly, a mecA homolog with 88% amino acid similarity to mecA in MRSA was 
identified in Staphylococcus sciuri (112, 113).  In addition, mecA homologs have also 
been discovered in Macrococcus caseolyticus (114, 115) and in Staphylococcus fleuretti, 
a commensal bacterium of animals (116, 117).  Based on similarities of the mecA region 
in these isolates and the discovery of mec allotypes in bovine MRSA isolates and other 
animals, it has also been suggested that animals may act as a potential source of a mecA 
precursor and for the emergence of new MRSA clones in human beings (53).  However, 
currently the origin of SCCmec is still unknown.  
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 It was formerly believed that the spread of MRSA was entirely due to clonal 
expansion of a few successful strains, and thus suggesting that de novo acquisition of 
SCCmec was quite rare.  Kreiswirth et al. concluded that S. aureus had acquired mecA on 
one occasion and that present MRSA clones were mere descendants of a prototypical 
isolate (118).  This conclusion is wrong, as more recent studies have indicated that the 
horizontal transfer of SCCmec is more frequent than previously thought.  For instance, 
identical SCCmec elements are present in unrelated staphylococcal strains, and even in 
different staphylococcal species, and different types of SCCmec elements are present in 
closely related strains (119-121).  Furthermore, the analyses of many epidemic MRSA 
isolates from hospitals in different countries by molecular methods, including MLST and 
DNA microarray analysis, reveal the existence of modern MRSA lineages that are 
unrelated to the first MRSA isolate.  These findings demonstrate that the SCCmec 
element has been horizontally transferred (120, 122, 123).  DNA microarray analysis 
from 36 MRSA isolates showed that the mecA gene was associated with five genetically 
divergent groups of isolates, and thus has been horizontally transferred into distinct S. 
aureus chromosomal backgrounds at least five times (122).  MRSA clones have also 
emerged from specific clonal complexes (CCs) on multiple occasions, resulting in 
isolates with the same MLST type that differ in SCCmec type (120).  Therefore, SCCmec 
has been transferred to S. aureus on more than five occasions as some lineages have 
acquired different SCCmec types, and recent studies have demonstrated that it has more 
likely transferred about 15 times (120).  In addition, with the emergence of CA-MRSA 
strains, MLST and SCCmec typing data have shown that CA-MRSA isolates are related 
distantly to HA-MRSA strains, demonstrating novel acquisitions of SCCmec (124).  
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These data are evidence that MRSA isolates are not diversified descendants over the last 
almost fifty years of an original MRSA clone, but rather that horizontal transfer of 
SCCmec into different S. aureus lineages has played a significant role in the evolution of 
MRSA.  
 Despite being transferred numerous times, some genetic backgrounds seem to be 
better adapted than others to acquire SCCmec or mecA.  Katayama et al. assessed the 
effect of the recipient background on the methicillin resistance phenotype by introducing 
plasmid-encoded mecA into various recipients (125).  Results demonstrated that 
“experienced” hosts, or strains that previously had SCCmec and lost it, had a resistance 
phenotype similar to that of the parental strain with SCCmec when plasmid-encoded 
mecA was introduced.  On the other hand, “naïve” hosts, or strains in which SCCmec had 
never been introduced, selected against mecA expression.  The authors also found that the 
mecA regulatory genes, mecI and mecR1, as well as the homologous β-lactamase 
regulatory genes, blaI and blaR1, helped permit the maintenance and expression of mecA 
in “naïve” hosts.  These data imply that there is a host barrier to SCCmec acquisition and 
that some strains may be better adapted, compensated, or prepared for it, but the genetic 
or biochemical basis for this observation is unknown.   
 The mechanism of horizontal transfer for SCCmec has yet to been determined. 
There are three mechanisms of HGT in bacteria: transformation, transduction, and 
conjugation.  Because S. aureus is not naturally competent, transformation as a means of 
transfer of SCCmec will be excluded.  Transduction is the transfer of genetic from one 
bacterium to another via a bacteriophage genetic vector.  It was the first genetic exchange 
mechanism discovered in staphylococci (126).  Staphylococcal bacteriophages typically 
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belong to serological groups A, B, and F, of which group B contains most of the known 
transducing phages (127).  Staphylococcal generalized transducing phages are of the P22 
type, and Φ11 and 80α, which are temperate S. aureus phages, are the most studied (128-
130).  Typically, transduction frequencies for plasmids range from 10-4 to 10-6, and for 
chromosomal markers frequencies range from 10-6 to 10-8 (126).  Staphylococcal 
transducing phages encapsidate genome-sized DNA fragments commensurate to the size 
of the phage genome.  Most of the widely used staphylococcal transducing phages have 
40-50 kb size genomes.  For plasmid transduction, those that are larger than the phage 
genome are truncated while those that are smaller are packaged as linear multimers 
during phage growth (131, 132).   
One of the first pieces of evidence that phage could be environmental vectors for 
the transfer of antibiotic resistance genes such as mecA was the detection of mecA in 71 
phage DNA samples from pigs, poultry, and cattle fecal wastes (133-135).  However, the 
authors failed to characterize this finding any further in relation to SCCmec, and the 
results were not surprising.  Recently, Scham et al. showed that both bacteriophage 80α 
and 29 were capable of transducing SCCmec type I and type IV to recipient strains of S. 
aureus at low frequencies and also that this transduction required extended selection 
times for mecA gene expression as well as the presence of a β-lactamase plasmid in the 
recipient (136).  The authors noted that there appeared to be a delicate balance between 
insertion of SCCmec and mecA expression in recipient strains, and that the role of the β-
lactamase plasmid was to help regulate mecA expression as previously mentioned above 
(125, 136).  SCCmec types I and IV are the smallest of SCCmec elements (20-25 kb) and 
thus may be easier to transduce via the phages used in this study, Φ11 and 29, which 
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package 40-50 kb of DNA.  This does not explain how the larger SCCmec elements may 
be transferred.  Equally important when considering transduction as a means for SCCmec 
transfer, phages have historically been assumed to be highly species specific, with a 
narrow host range (126, 137).  This would imply that phage-mediated genetic exchange 
would be highly restricted within a species, yet it is known that identical SCCmec 
elements exist in S. epidermidis and S. aureus.  Recently though, Chen and Novick have 
reported that SaPIs have transferred via phage from S. aureus to Listeria monocytogenes 
at the same high frequencies that they transfer in S. aureus (138).  What is important to 
note in this study, is that while these staphylococcal phages transduced L. monocytogenes 
they failed to form plaques.  This is important because the observed “silent” phage-
mediated transfer of DNA without infection that can only be assessed by gene transfer 
potentially widens the host range of phages previously thought to be restricted.  Other 
studies have also described interspecies transfer among staphylococci mediated by phage 
(176-179).  These studies involve the SaPIs which transfer at a high frequency, and a 
defined mechanism for the interspecies transduction has not been determined.  
Bacterial conjugation has the broadest host range among the mechanisms for 
HGT and has been shown to occur in both Gram-negative and Gram-positive bacteria and 
also between the two groups (137, 139).  It allows for the transfer of DNA from a donor 
to a recipient through direct cell-to-cell contact (140).  The study of Gram-negative 
conjugative plasmids, such as F, RP4, and others, has significantly contributed to the 
genetic and molecular understandings of bacterial conjugation.  Specifically, plasmid 
DNA transfers from donor to recipient as a linear, single strand via the help of two well-
conserved elements: i) the origin of transfer, oriT, where DNA transfer initiates and 
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terminates, and ii) a site-specific endonuclease that cleaves a single strand of DNA at the 
nic site (141).  The endonuclease proteins, relaxases, bind to the oriT region to form a 
DNA-protein complex referred to as the relaxosome.  After relaxosome formation, 
cleavage of a single strand of DNA occurs at the oriT site and DNA is transferred into the 
recipient cell in the 5’ to 3’ direction via a specialized multiprotein complex named the 
conjugation apparatus (141).  The conjugation apparatus appears to be a subgroup of type 
IV secretion systems that have evolved the capacity to translocate DNA (142).  One of 
the best-studied conjugative systems is the IncP transfer (tra) system of the Gram-
negative conjugative plasmid, RP4 (143, 144).  This system demonstrates the importance 
of two protein complexes, the relaxosome, discussed above, and the mating-pair 
formation (Mpf) complex (145).  The Mpf complex, encoded by the conjugative plasmid, 
is a multiprotein complex that is involved in trafficking the donor DNA into the recipient 
cell.  Eleven Mpf components (trbB to trbL and traF) are required for forming the IncP 
pilus and conjugative junctions (144, 145).  
Gram-positive conjugation systems have only recently been studied in the same 
detail as those of Gram-negative bacteria.  The obvious major difference between the two 
systems is the machinery necessary to establish cell-to-cell contact.  Although no 
structural studies have been performed on the Gram-positive conjugative apparatus, it can 
be inferred that they would not require such sophisticated structures as pili to achieve 
direct cell-to-cell contact, resulting in simpler tra functions.  Most staphylococci 
conjugative plasmids range in the size of 40-60 kb, maintain low copy numbers, and 
carry multiple resistance markers (126).  While most conjugative plasmids to date in 
streptococci and enterococci show broad host range, those found in staphylococci seem to 
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be limited to the genus Staphylococcus (146, 147).  Staphylococcal conjugative transfer 
frequencies are usually in the range of 10-5 to 10-6 per donor cell and can depend on the 
plasmid and the mating-pair genotype (126).   
Conjugative plasmids in staphylococci were discovered in conjunction with the 
emergence and spread of gentamicin resistance in U.S. hospitals in the mid-1970s (148, 
149).  Interspecies conjugative transfer was demonstrated by the presence of conjugative 
plasmids with identical restriction patterns in S. aureus and S. epidermidis hospital 
isolates from the same patient (148, 150, 151).  Two fully sequenced and well-
characterized prototypical conjugative plasmids from S. aureus are pSK41 (152, 153) and 
pGO1 (154, 155, 165).  Plasmid pGO1 was the first Gram-positive staphylococcal 
conjugative plasmid subjected to intense genetic analysis to understand its conjugation 
functions and transfer.  It is a 52 kb plasmid that transfers among staphylococci broadly 
but is restricted to members of this genus.  It also encodes resistance to gentamicin, 
neomycin,  trimethoprim and quaternary ammonium compounds (155).  Genetic analysis 
revealed two distinct regions on the plasmid necessary for conjugation: i) a 13.6 kb 
conjugative transfer region (trs) consisting of fourteen open reading frames (ORFs), and 
ii) a 2.2 kb region harboring the origin of transfer (oriT) and the gene encoding the oriT 
nicking protein (Nes) (156).  The pGO1 oriT is identical to sequences of oriT sites in 
Gram-negative conjugative plasmids, and the trs genes are analogous to the tra functions 
of Gram-negative plasmids as well.  The trs genes encode for a transmembrane 
conjugative apparatus that the relaxosome (Nes-oriT complex) couples to and transfers a 
single strand of pGO1 DNA from the donor into a recipient cell  (154, 155).  Small 
nonconjugative plasmids that have a nicking site (mobS) and encode proteins necessary 
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for nicking activity and relaxosome formation (MobA and MobB) can be mobilized by 
pGO1 (157, 158).  
Plasmid pGO1 also contains nine copies of IS431/IS257, and eight of these are 
directly repeated which is important for plasmid evolution  (159, 160, 165).  Derivatives 
of pGO1 were described after discovering plasmids encoding mupirocin resistance that 
could be transferred among S. aureus recipients and were incompatible with pGO1  (161-
163) .  Further DNA sequence analysis revealed that the mupirocin resistance gene had 
integrated into pGO1 by recombination at IS elements and that this derivative also 
subsequently lost genes encoding resistance to gentamicin, neomycin, and trimethoprim, 
which were also flanked by IS elements.  This pGO1 derivative is referred to as pGO400 
and is 34 kb.  Plasmid pGO400 and other derivatives appear following multiple transfers 
and recombination at IS copies  (164) .  These derivatives demonstrate the importance of 
IS elements for conjugative plasmid evolution and may serve as a model for the mobility 
of other staphylococcal resistance genes.  
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CHAPTER 2 
 
 
Materials and Methods 
 
 
Bacterial culture conditions.  Bacterial strains used in these studies are listed in Table 1.  
S. aureus and S. epidermidis strains were cultured in tryptic soy broth (TSB) or on tryptic 
soy agar (TSA) (Difco, Lawrence, KS), and Escherichia coli cells were cultured in Luria-
Bertani (LB) broth or agar (Difco, Lawrence, KS).  All bacteria were grown aerobically 
and at 37°C unless otherwise stated.  Broth cultures were grown shaking at 200 rpm with 
a 1:5 liquid to air ratio.  The antibiotics and concentrations, used when appropriate for 
selection, were as follows: ampicillin (100 µg/ml), chloramphenicol (10 µg/ml), 
tetracycline (10 µg/ml), erythromycin (10 µg/ml), kanamycin (20 or 100 µg/ml), 
mupirocin (10 µg/ml), rifampin (10 µg/ml), and novobiocin (5 µg/ml) (Sigma-Aldrich, St. 
Louis, MO).   
 
Genomic DNA isolation.  For isolating genomic DNA to be used as DNA templates in 
polymerase chain reaction (PCR) assays, the QIAGEN DNeasy Blood and Tissue 
Handbook Kit was used according to manufacturer’s instructions (QIAGEN, Valencia, 
CA).  For quick check of DNA in individual colonies for cloning screening purposes, 
DNA was isolated from a single colony by resuspending a very small amount of the 
colony in 20 µl of HPLC grade water (Mallinckrodt Baker, Pillipsburg, NJ) which was 
then heated in the microwave for one minute exactly. One µl of the released DNA and 
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ruptured cell mixture was used for PCR amplification. This form of isolated DNA cannot 
be saved for long term and was discarded after use.  To isolate high-quality DNA for 
whole genome sequencing, the QIAamp DNA Blood Mini Kit was used following the 
manufacturer’s protocol for the QIAGEN Maxi tip 500/G (QIAGEN, Valencia, CA).  To 
isolate DNA from phage virions (discussed in “Phage precipitation”), phenol-chloroform 
extraction was performed.  An equal volume of a 25:24:1 mixture of 
phenol:chloroform:isoamyl alcohol (Sigma, St. Louis, MO) was added to the phage 
virion sample, vortexed for 20 seconds, incubated at room temperature for 5 minutes, 
then centrifuged at 13,000 rpm for 15 minutes at 4°C.  The aqueous phase was carefully 
transferred to a new tube, and 0.1 volume of 3M NaOAc pH 5.2 and 2 volumes of ice-
cold 100% ethanol were added, mixed by inversion, and incubated overnight at -20°C. 
The DNA was pelleted by centrifugation at 13,000 rpm for 30 minutes at 4°C and rinsed 
by adding 1 ml of cold 70% ethanol and centrifuging for 10 minutes at 13,000 rpm and 
4°C.  The ethanol was removed and the DNA pellet was allowed to air dry and 
resuspended in 40 µl of HPLC grade water (Mallinckrodt Baker, Pillipsburg, NJ). 
 
Plasmid DNA isolation.  Plasmids used in these studies are listed in Table 1.  Plasmids 
were isolated from 3 ml of an overnight culture of E. coli or S. aureus using a QIAprep 
Spin Miniprep kit (QIAGEN, Valencia, CA) as described by the manufacturer.  When 
plasmids were isolated from S. aureus, 1µg/ml lysostaphin (Sigma, St. Louis, MO) was 
added to the lysis solution provided and incubated at 37°C for one hour. Then the 
isolation procedure was continued according to the manufacturer’s protocol.  Plasmids 
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were analyzed by digesting with restriction enzymes (NEB, Ipswich, MA) and running on 
agarose gels or sent for sequencing (Eurofins MWG Operon, Huntsville, AL). 
 
Polymerase chain reaction (PCR).  Polymerase chain reactions were performed in a 
Bio-Rad PTC-0200 DNA Engine thermal cycler (Bio-Rad, Hercules, CA).  Primers used 
for PCR are listed in Table 2.  Primers were ordered from Eurofins MWG Operon 
(Huntsville, AL).  100 µM primer stock solutions were prepared in HPLC grade water 
(Mallinckrodt Baker, Pillipsburg, NJ) and working stocks were diluted to 10 µM.  
Endpoint PCR was performed using a TopTaq DNA polymerase kit (catalog number 
200201) and following manufacturer’s instructions (QIAGEN, Valencia, CA).   Typical 
PCR reaction conditions were as follows: one initial cycle at 95°C for 3 minutes followed 
by 30 cycles of [94°C 30 seconds to denature, (Primer melting temperature in °C -5 )°C 
30 seconds for hybridization, 70°C one minute per kb for extension] followed by a final 
extension at 70°C for 10 minutes and then chilled to 12°C.  PCR products were purified, 
if necessary, using the QIAGEN PCR purification kit following manufacturer’s 
instructions (QIAGEN, Valencia, CA) to be used for DNA mutagenesis or sent for 
sequencing (Eurofins MWG Operon, Huntsville, AL). 
 
Agarose gels.  1% agarose gels were prepared by dissolving agarose (Fisher Scientific, 
Pittsburgh, PA) in 0.5X TBE (40 mM Tris-HCl pH 8.3, 45 mM boric acid, 1 mM EDTA) 
at 100°C.  Ethidium bromide was added to 0.1 µg/ml prior to pouring the gels.  5X 
loading dye (50% glycerol, 0.25% bromophenol blue in TBE buffer) was added to the 
DNA solution to a final dye concentration of 1X if a compatible dye was not already 
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added in the PCR reaction.  The DNA-dye mixture was loaded in agarose gels and 
subjected to electrophoresis in 0.5X TBE running buffer at 120 volts until the dye front 
had migrated roughly 75% the length of the gel.  The gel was then visualized under UV 
light (302-312 nm).  The size of the DNA fragments was measured against either a 1 kb 
ladder or a 100 bp ladder (NEB, Ipswich, MA).  DNA fragments were purified, if 
necessary, using the QIAGEN Gel Purification kit following manufacturer’s protocol 
(QIAGEN, Valencia, CA) to be used for DNA mutagenesis or sent for sequencing 
(Eurofins MWG Operon, Huntsville, AL). 
 
Chromosomal DNA deletion mutant construction.  Chromosomal deletions were 
performed by allelic replacement mutagenesis, using vector pKOR1 as discussed in the 
“allelic exchange” section. This plasmid allows efficient cloning without the use of 
restriction enzymes and ligase and instead relies on the phage lambda recombination 
system.  One kb fragments, one upstream and one downstream of the desired region to be 
deleted, were amplified by PCR.  A restriction enzyme recognition site was incorporated 
at the 3’ end of the upstream 1 kb fragment and at the 5’ end of the downstream 1 kb 
fragment by PCR.  The 5’ end of the 1 kb upstream fragment contained an attB1 site 
while the 3’ end of the 1 kb downstream fragment contained an attB2 site.  PCR products 
were digested with the appropriate restriction enzyme (NEB, Ipswich, MA) and ligated 
overnight using T4 DNA ligase (NEB, Ipswich, MA).  Two µl of the ligated product was 
mixed with 1 µl of purified plasmid pKOR1 and 2 µl of BP clonase II enzyme 
(Invitrogen, Carlsbad, CA) (for lambda recombination at attB sites on the insert and attP 
sites on pKOR1) and incubated at room temperature for 5 hours, then introduced into E. 
	   26	  
coli TOP10 competent cells by transformation*. The resulting plasmid was isolated from 
E. coli*, introduced into RN4220 by electroporation*, and transduced into the S. aureus 
target strain* for allelic exchange*.  
*discussed in other sections 
 
Chromosomal DNA insertion mutant construction.  Instead of relying on standard 
techniques such as gene splicing by overlap extension, a new method was used to 
construct gene insertion mutations in target strains without the introduction of extra 
restriction sites.  The In-Fusion HD Cloning Kit (Clontech, Mountain View, CA, catalog 
number: 639648) was used following manufacturer’s instructions.  This system allows for 
directional cloning of one or more fragments of DNA into any vector.  For allelic 
exchange mechanisms to insert a desired gene in a S. aureus chromosome three 
fragments of DNA were generated: 1) 1 kb of DNA immediately upstream of the desired 
gene insertion site 2) the gene to be inserted 3) 1 kb of DNA immediately downstream of 
the desired gene insertion site.  PCR primers were designed to introduce 15 bp 5’ 
extensions that were complementary to the ends of the adjoining fragment, and the outer 
most fragments contained 15 bp 5’ extensions that were complementary to the ends of the 
linearized vector (pUC18).  The In-Fusion cloning reaction was set up following 
manufacturer’s instructions, and In-Fusion Enzyme fused the DNA fragments forming a 
final circular plasmid construct containing combined insert of 1 kb of DNA upstream of 
the desired gene insertion site-gene of interest to be inserted and 1 kb of DNA 
downstream of the desired gene insertion site.  Three µl of this fusion reaction were 
transformed with E. coli TOP10 competent cells (Invitrogen, Carlsbad, CA). Following 
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confirmation of the insert in pUC18 by restriction analysis, PCR, and sequencing, 
primers were designed containing attB sites (for lambda recombination with pKOR1) to 
amplify the insert by PCR for cloning into pKOR1 (as discussed in “Chromosomal DNA 
deletion mutant construction”). 
 
Site-directed mutagenesis.  Single nucleotide polymorphisms (SNPs) were introduced 
using site-directed mutagenesis.  Briefly, the area of interest was amplified by PCR and 
cloned into the pUC18 vector (2.7 kb) by restriction digestion followed by ligation.  
“Around the Horn” mutagenesis was performed by designing overlapping forward and 
reverse primers that contained the desired SNPs and then using the QuikChange 
Lightning Site-Directed Mutagenesis kit (Agilent Technologies, Santa Clara, CA, catalog 
number: 210219) following manufacturer’s protocol.  SNPs were confirmed by 
sequencing (Eurofins MWG Operon, Huntsville, AL) the region on plasmid purified from 
E. coli.  Following confirmation of the mutations in the target region on pUC18, primers 
were designed containing attB sites (for lambda recombination with pKOR1) and the 
region of interest containing SNPs was amplified by PCR*, analyzed by gel 
electrophoresis on 1% agarose gels*, and gel purified* for cloning into pKOR1 
(discussed in “Chromosomal DNA deletion mutant construction”). 
*discussed in other sections 
 
Transformation of E. coli.  Plasmid DNA (3 µl) of constructed plasmids discussed in 
mutagenesis sections was added to 50µl of One Shot® TOP10 Chemically Competent E. 
coli cells [F- mcrA Δ(mrr-hsdRMS-mcrBC) Φ80lacZΔM15 ΔlacX74 recA1 araD139 
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Δ(araleu)7697 galU galK rpsL (StrR) endA1 nupG] (Invitrogen, Carlsbad, CA).  The 
mixture was incubated on ice for 30 minutes then immersed in a 42°C water bath for 45 
seconds.  One ml of SOC (2% tryptone, 0.5% yeast extract, 85.5 mM NaCl, 2.5 mM KCl, 
10 mM MgCl2, 20 mM glucose) was added and the cells were allowed to recover by 
incubating at 37°C with shaking at 200 rpm for one hour.  Following recovery the cells 
were plated on LB agar plates with appropriate antibiotic selection (usually ampicillin 
100 µg/ml for most plasmids used when expressed in E. coli). The plates were incubated 
overnight at 37°C and bacterial colonies were analyzed the following day. 
 
Preparation of electrocompetent S. aureus cells.  Electrocompetent S. aureus cells 
were prepared from 50 ml of RN4220 grown in TSB to exponential phase (OD600nm = 
0.6-0.8).  All subsequent steps were on ice to keep the cells cold and each washing step 
was followed by centrifugation at 4,000 rpm, 4°C, for 15 minutes.  The cultures were 
collected by centrifugation for 15 minutes at 4,000 rpm at 4°C.  The pellet was washed 
three times with 25 ml of ice-cold sterile water.  The pellet was then washed one time in 
25 ml of ice-cold sterile 10% glycerol.  The pellet was then resuspended in 500 µl of ice-
cold sterile 10% glycerol and incubated at room temperature for 15 minutes.  
Resuspended cells were dispensed into 50 µl aliquots and stored at -80°C.  Frozen 
competent cells were discarded after six months. 
 
Transformation of S. aureus.  Plasmid DNA (5 ng-2 µg) isolated as discussed in the 
“Plasmid isolation” section was added to 50 µl of electrocompetent S. aureus cells and 
incubated on ice for 30 minutes.  The mixture was then transferred to an electroporation 
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cuvette with a gap length of 0.1 cm and pulsed one time using the Gene Pulser I (Bio-
Rad, Hercules, CA) set to the following conditions: 2.5 kV, 25 µF, and 100 Ω yielding a 
field strength of 12.5 kV and a time constant of approximately 2.5 ms.  Following 
electroporation, 1 ml TSB (including a subinhibitory concentration of antibiotic when 
necessary- 1:50 dilution of standard selection concentration) was added to the cells and 
then transferred to a 15ml conical tube (Fisher Scientific, Pittsburgh, PA) and incubated 
for 2 hours with shaking at 200 rpm at 37°C or at 30°C for the temperature-sensitive 
plasmid pKOR1 used in allelic exchange.  Aliquots of 100 µl were then spread on at least 
three TSA plates supplemented with antibiotic for selection and grown overnight at 37°C 
or 30°C, depending on permissive temperatures of the plasmid. 
 
Phage Transduction. The generalized transducing bacteriophage 80α was used to move 
plasmids from RN4220 into new recipient strains for allelic exchange discussed in the 
“Allelic exchange” section or to move SCCmec from 450M into an isogenic recipient.  
80α phage titers were determined as described in “Determination of phage titers” and 
RN4220 containing the plasmid to be transduced or 450M was infected at a M.O.I. of 1.0.  
4 ml TSA soft agar (TSB supplemented with 0.5 M CaCl2 and 0.4% BactoTM Agar 
(Difco, Lawrence, KS)) was added to the phage and bacterial cell mixture and poured 
over a TSA plate, which was then incubated overnight at 30°C.  Five ml phage buffer (1 
mM MgSO4, 4 mM CaCl2, 0.05 M Tris-HCl pH 7.8, 100 mM NaCl, 0.1% gelatin) was 
added to the plate and the TSA soft agar was lightly homogenized.  The mixture was 
centrifuged at 4,000rpm for 15 minutes at 4°C and the supernatant was filter sterilized 
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using a 0.45 µm pore-size filter (EMD Millipore, Darmstadt, Germany).  The phage 
lysate was stored at 4°C. 
 The 80α lysate containing the plasmid of interest was used to infect a recipient 
strain at an M.O.I. of 1.0.  4ml TSB supplemented with 0.5M CaCl2 was added to the 
mixture and the culture was incubated for 30 minutes at 30°C for infection.  Following 
infection, 5ml ice-cold 20mM sodium citrate was added the culture was and centrifuged 
at 4,000 rpm for 15 minutes at 4°C.  The pellet was washed twice with 2ml ice-cold 
20mM sodium citrate and centrifuged at 4,000 rpm for 15 minutes at 4°C.  Finally, the 
pellet was resuspended in 1 ml TSB and serially diluted on TSA plates supplemented 
with 5 mM sodium citrate and the appropriate antibiotic for selection. 
 
Determination of phage titers.  Phage titers were determined by plating serial dilutions 
of a phage lysate on a sensitive S. aureus indicator strain (RN4220).  A 100 µl aliquot of 
each phage lysate dilution was added to 100 µl of a bacterial culture of RN4220, mixed 
with 2 ml of TSA soft agar (TSB supplemented with 0.5 M CaCl2 and 0.4% BactoTM 
Agar (Difco, Lawrence, KS).  The mixture was poured onto a TSA plate and incubated 
overnight at 30°C.  Phage plaques were counted the next day to determine the phage titer 
expressed as plaque forming units (PFU) per ml (PFU/ml). 
 
Allelic exchange.  The plasmid pKOR1 was used for allelic exchange because it has 
positive selection for secondary recombination.  A colony of S. aureus containing 
pKOR1 with the desired insert for allelic exchange (discussed in “Chromosomal DNA 
mutant construction”) was grown at 30°C in TSB supplemented with chloramphenicol 
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(10 µg/ml) overnight and then at 42°C the next day to inhibit replication of the 
temperature-sensitive plasmid in order to favor integration of the plasmid via 
recombination of the 1 kb homologous regions of DNA on the plasmid with homologous 
regions on the chromosome.  Cultures were then grown on TSA plates supplemented with 
chloramphenicol (5 µg/ml) and large colonies were picked and cultured in TSB at 30°C at 
the permissive temperature for plasmid replication to allow the plasmid to excise from 
the chromosome via a second recombination event.  The cultures were then plated on 
TSA plates containing 200 ng/ml anhydrotetracycline (Clontech, Mountain View, CA).  
Plasmid pKOR1 contains an antisense construct to the essential gene secY that is driven 
by a tetracycline-inducible promoter.  Any cells that still contain the integrated plasmid 
and have not undergone secondary recombination will not grow after tetracycline 
induction. Individual colonies that did grow following tetracycline induction were 
streaked onto TSA and TSA plates supplemented with chloramphenicol (5 µg/ml) to 
confirm sensitivity and loss of the plasmid.  PCR analysis and sequencing (Eurofins 
MWG Operon, Huntsville, AL) were performed to confirm that the target strains had the 
desired mutations.  
 
Phage precipitation.  Phage lysates were filter sterilized using a 0.45 µm pore-size filter 
(EMD Millipore, Darmstadt, Germany) to remove cellular debris. The sample was treated 
with 2U DNAseI (NEB, Ipswich, MA) per ml of lysate at 37°C for 1 hour to remove any 
bacterial extracellular DNA that may be present. The DNaseI was then inactivated by 
incubating at 75°C for 10 minutes. Polyethylene glycol 8000 (PEG) and NaCl were 
dissolved in the DNaseI-treated lysate to a final concentration of 0.1% and 5 M, 
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respectively, and incubated overnight at 4°C.  The next day, the lysate was centrifuged at 
7,000 rpm 4°C for 20 minutes.  The supernatant was decanted and the PEG phage 
precipitate was resuspended in phage buffer (1 ml per 100 ml of original lysate).  An 
aliquot of supernatant was saved as the DNaseI treatment control.  Encapsidated DNA 
was isolated from the phage virions using phenol-chloroform extraction discussed in the 
“genomic DNA isolation” section and was then subjected to PCR analysis. 
 
Infective endocarditis rabbit model.  All animal procedures were approved by the 
Institutional Animal Care and Use Committee of Virginia Commonwealth University 
(permit AM10030) under the supervision of Dr. Todd Kitten and were compliant with all 
institutional policies and federal guidelines, including the USDA Animal Welfare Act 
and the Public Health Service Policy on the Humane Care and Use of Laboratory 
Animals.  
New Zealand male white rabbits (2-3 kg) were purchased from RSI 
Biotechnology and housed in the Virginia Commonwealth University animal suite for 
one week prior to experimentation to allow the animals to acclimate and to monitor their 
behavior under normal conditions.  The rabbits were anesthetized and a 19-gauge catheter 
(BD Bioscience, San Jose, CA) was inserted through the right internal carotid artery past 
the aortic valve to cause minor damage.  The catheter remained in the artery throughout 
the experiment.  Following surgery, the incision was closed with surgical clips.  Animals 
were monitored until fully recovered from the surgery and returned to normal activity.  
Every 12 hours until the completion of the experiment rabbits received 0.03 mg/kg of 
buprenorphine as analgesia.  Two days following catheterization, 500 µl of S. aureus 
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MR14 at 3.77x106 CFU/ml was inoculated into the bloodstream via introduction in the 
peripheral ear vein.  Three days post-infection, rabbits were euthanized by intravenous 
injection of Euthasol (Virbac, Fort Worth, TX).  Necropsy was performed and bacterial 
vegetations were removed from the heart.  The vegetations were then homogenized in 1X 
phosphate buffered saline (PBS) (137 mM NaCl, 2.7 mM KCl, 4.3 mM Na2HPO4, 1.47 
mM KH2PO4), serially diluted, and plated on TSA and TSA supplemented with 
tetracycline (10 µg/ml) and grown overnight at 37°C.  The following day colonies were 
counted to determine the number of CFU/g tissue.  
 
Conjugative filter mating.  Overnight TSB cultures of donor and recipient strains grown 
in the presence of appropriate antibiotic selection were mixed in a 1:1 ratio (2 ml of 
donor strain and 2 ml of recipient strain).  The combined cells were centrifuged at 4,000 
rpm, 4°C, for 15 minutes and washed once with 1X PBS (137 mM NaCl, 2.7 mM KCl, 
4.3 mM Na2HPO4, 1.47 mM KH2PO4).  The combined cell pellet was resuspended in 2 
ml 1X PBS and forced through a sterile syringe onto a 25 mm diameter, 0.45 µm pore-
size nitrocellulose filter (EMD Millipore, Darmstadt, Germany).  The filter was placed on 
TSA agar in the absence of antibiotic pressure, bacteria side up, and was incubated at 
37°︎C overnight.  Cells were vortexed off of the filters in 1 ml of 1X PBS and were plated 
on TSA containing appropriate antibiotics, selecting for donors, recipients, and 
transconjugants (noted in Results and Table 1).  Mating frequencies were expressed as 
the number of transconjugants CFU/ml divided by the number of donors CFU/ml.  
 
	   34	  
Pulsed-field gel electrophoresis (PFGE).  Bacterial strains subjected to PFGE analysis 
were streaked on TSA plates supplemented with appropriate antibiotic(s) and grown 
overnight at 37°C.  Overnight cultures were then prepared from a single colony in TSB 
supplemented with appropriate antibiotic(s) and grown at 37°C with shaking at 200 rpm.  
Agarose plugs containing bacterial cells in suspension were then prepared.  Aliquots 250 
µl of the overnight cultures were centrifuged at 10,000 rpm for 5 minutes and the pellet 
was washed in 1X PBS (137 mM NaCl, 2.7 mM KCl, 4.3 mM Na2HPO4, 1.47 mM 
KH2PO4) and then resuspended in 250 µl 1X PBS, followed by addition of 300µl of PIV 
buffer (10 mM Tris-HCl pH 7.6, 1 M NaCl).  Low melting agarose (Fisher Scientific, 
Pittsburgh, PA; catalog number BP165-25) was dissolved in double-distilled water 
(ddH2O) at 100°C to a final concentration of 2% and 300 µl of this was then added to the 
cells and PIV buffer mixture and vortexed.  Ten µl of a 1 mg/ml lysostaphin stock 
(Sigma, St. Louis, MO) was added to the suspension and mixed by inverting the tubes 
several times.  Approximately 80 µl of the cells/agarose/lysostaphin mixture was added to 
each slot in a plug mold, yielding six plugs per bacterial strain.  The agarose plugs were 
allowed to solidify at room temperature for 20 minutes.  The six plugs for each strain 
were combined in 5 ml of EC buffer (6 mM Tris-HCl pH 7.5, 1 M NaCl, 100 mM EDTA, 
0.5% Brij-58, 0.2% sodium deoxycholate, 0.5% sarkosyl) in a 15 ml conical tube and 
incubated at 37°C for 1-3 hours for bacterial cell lysis as monitored by visual clearing of 
plugs.  After lysis, the EC buffer was decanted and 5ml ESP buffer (0.5M EDTA, 1% 
sarkosyl, pH 9.0) was added in addition to 5 µl of proteinase K (20mg/ml) (Life 
Technologies, Grand Island, NY) and incubated in a 55°C water bath overnight.  The 
next day, the plugs were washed with gentle shaking at room temperature with many 
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exchanges of ddH2O throughout the day, changing the water every 30 minutes.  After 
washing, the water was decanted and 5 ml 1X TE buffer (10 mM Tris-HCl pH 7.5, 1 mM 
EDTA) was added.  Plugs prepared in this way can be stored at 4°C for up to six months. 
DNA in the plugs was digested by restriction enzymes NarI or SacI (NEB, Ipswich, MA), 
where noted, in a 400 µl reaction volume with 120U restriction enzyme per plug.  A 1% 
agarose gel was prepared by dissolving SeaKem Gold Agarose (Lonza) in 0.5X TBE.  
Plugs were loaded into the gel, along with a MidRange II PFG marker (NEB, Ipswich, 
MA) and overlaid with 1% SeaKem Gold Agarose (Lonza) in 0.5X.  The gel was placed 
in a CHEF-DR III Pulse Field Electrophoresis System (Bio-Rad, Hercules, CA) and the 
following settings were used for electrophoresis: 6 volts/cm, 1 second initial switching 
time, 30 seconds final switching time, 22 hour run time, 14°C, 120° included angle). 
 
Southern blot.  Pulsed-field DNA gels were soaked for 10 minutes in 0.2 N HCl to 
depurinate the DNA and then rinsed in ddH2O.  Gels were then soaked in denaturation 
solution (1.5 M NaCl, 0.5 N NaOH) for 45 minutes, rinsed with distilled water, and 
soaked in neutralization solution (1 M Tris-HCl pH 7.4, 1.5 M NaCl) for 30 minutes, then 
rinsed in ddH2O and soaked in fresh neutralization solution for 15 minutes.  SSC buffer 
solutions used below were prepared from a 20X SSC (3 M NaCl, 0.3 M sodium citrate, 
pH 7.0) stock solution.  A positively charged nylon membrane (Roche, Mannheim, 
Germany) and five pieces of Whatman 3MM paper were cut slightly larger than the gel. 
The nylon membrane was submerged in distilled water, and once completely wet was 
transferred to 2X SSC buffer. A reservoir tank was filled with 10X SSC, a glass plate was 
used as a platform upon which a piece of Whatman 3MM paper was placed which was 
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used to wick the 10X SSC solution through the transfer apparatus. The gel was placed 
upon the Whatman 3MM paper and surrounded with parafilm. The nylon membrane was 
placed on the gel followed by five pieces of Whatman 3MM soaked in 2X SSC. A 10cm 
stack of paper towels, a glass plate and a weight of approximately 500g were layered on 
top of the gel. The capillary transfer proceeded for 24 hours.  After transfer, the nylon 
membrane was allowed to dry at room temperature for at least 30 minutes.  The DNA 
was then fixed to the membrane by UV irradiation in a UV Stratalinker 2400 (Stratagene, 
La Jolla, CA) at 120,000 µjoules/cm2. The membrane was either stored dry at 4°C or 
subjected immediately to hybridization and detection. 
 
Probe construction.  Full-length mecA and mupirocin gene purified PCR products were 
randomly primed and labeled with Digoxigenin-11-2’-deoxy-uridine-5’-triphosphate 
(DIG-11-dUTP) using the DIG DNA Labeling and Detection Kit (Roche, Mannheim, 
Germany, catalog number: 11093657910) following manufacturer’s protocol.  Briefly, 
10ng-3µg of purified DNA was denatured at 95°C for 10 minutes and quickly chilled on 
ice.  Reaction conditions contained hexanucleotide mix for random priming, dNTP- 
labeling mix including DIG-11-dUTP, and Klenow enzyme.  The reactions were 
incubated overnight and then stopped by heating at 65°C for 10 minutes. Labeling 
efficiency was determined following manufacturer’s instructions using included DIG-
labeled control DNA. 
 
Hybridization and detection.  Nylon membranes were prehybridized in an appropriate 
volume (20 ml/100 cm2 membrane) of DIG Easy Hyb buffer (Roche, Mannheim, 
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Germany) at 42°C.  The hybridization temperature (TH) was determined by TM - 20°C.  
TM = 49.82 + 0.41(%GC) – (600/L) where L = length of DNA in bp.  The mecA PCR 
product was 2,007 bp with 30.64% GC and the mupirocin PCR product was 3,075 bp 
with 28.75% GC.  Primers used are listed in Table 2.  Following prehybridization, 25 
ng/ml DIG-labeled DNA probes were denatured at 95°C for 5 minutes and rapidly cooled 
on ice.  The denatured probes were added to an appropriate volume (3.5 ml/100 cm2 
membrane) of pre-heated DIG Easy Hyb buffer (Roche, Mannheim, Germany) and mixed 
well.  The prehybridization solution was decanted from the membranes and the probe-
Hyb buffer mixtures were added to the membranes and incubated overnight in tightly 
sealed Tupperware containers with gentle agitation at 42°C.  Following hybridization, the 
membranes were washed twice at room temperature in low stringency wash solution (2X 
SSC, 0.1% SDS) for 5 minutes each with shaking, and twice for 15 minutes at 42°C with 
shaking in high stringency wash solution (0.5X SSC, 0.1% SDS).  Next, immunological 
detection was performed using the DIG DNA Labeling and Detection Kit (Roche, 
Mannheim, Germany, catalog number: 11093657910) following manufacturer’s protocol 
and using supplied reagents. DIG-labeled hybrids were detected with an anti-DIG-
alkaline phosphatase conjugate and visualized with the substrates NBT (nitroblue 
tetrazolium salt) and BCIP (5-bromo-4-chloro-3-indolyl phosphate, toluidinium salt) 
which produced a purple precipitate.  Briefly using supplied reagents in the DIG Wash 
and Block Buffer Set (Roche, Mannheim, Germany, catalog number: 11585762001), 
membranes were rinsed for 2 minutes in washing buffer, incubated for 30 minutes in 100 
ml blocking solution, incubated for 1 hour in 20 ml antibody solution, washed twice for 
15 minutes each in 100 ml washing buffer, and equilibrated for 5 minutes in 20 ml 
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detection buffer.  The membrane was then incubated in 10ml freshly prepared color 
substrate solution in the dark without shaking.  When the desired spot intensities were 
achieved the reaction was stopped by washing the membranes for 5 minutes in ddH2O 
and results were documented by photography.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
	   39	  
Strains Relevant characteristics Reference or Source 
E. coli TOP10 F- mcrA Δ(mrr-hsdRMS-mcrBC) 
Φ80lacZΔM15 ΔlacX74 recA1 araD139 
Δ(araleu)7697 galU galK rpsL (StrR) 
endA1 nupG 
Invitrogen 
S. aureus NCTC 8325 MSSA; NRS077 NARSA1 
S. aureus RN450 NCTC8325 cured of ︎ Φ︎11, Φ︎12, and ︎ Φ︎13 128 
S. aureus RN4220 Restriction-defective derivative of RN450 121 
S. aureus 450M 450 transformed with COL SCCmec type I 
region DNA 
180 
S. aureus 450MEX MSSA; SCCmec excised from 450M This work 
S. aureus MW2 MRSA strain carrying SCCmec type IV  181 
S. aureus MW2EX MSSA; SCCmec excised from MW2 This work 
S. aureus N315 MRSA strain carrying SCCmec type II 182 
S. aureus N315EX MSSA; SCCmec excised from N315 This work 
S. aureus MR4 450M ΔmecA-ψIS1272::tetM  This work 
S. aureus MR10 450MEX with orfX SNPs This work 
S. aureus MR14 N315 with modified SCCmec (ΔTn554 
Δ15.4kb attL::tetM) 
This work 
S. aureus MR14EX MSSA; SCCmec excised from MR14 This work 
S. aureus Cowan I MSSA; NRS104 NARSA1 
S. aureus HT20020238 MSSA; NRS242 NARSA1 
S. aureus MSSA476 MSSA clinical isolate 183 
S. aureus 18-1-2 MSSA clinical isolate 90 
S. epidermidis VCU113 MSSE clinical isolate 184 
S. epidermidis VCU129 MSSE clinical isolate 184 
pKOR1 Allelic replacement shuttle vector 185 
 
pGO400 pGO1 conjugative derivative  164 
pWA46 N315 ccrAB cloned downstream P-cadC in 
pCN38 
71 
pWA43 MW2 ccrAB cloned downstream P-cadC in 
pCN38 
71 
pCN36 pCN vector tetracycline resistance 186 
pET30a E. coli cloning vector Novagen 
pUC19 E. coli cloning vector Invitrogen 
pRM08 pKOR1 Δ15.4kb insert This work 
pRM11 pET30a ΔmecA-ψIS1272::tetM This work 
pRM13 pKOR1 ΔmecA-ψIS1272::tetM This work 
pRM19 pUC19 orfX This work 
pRM20 pUC19 orfX SNPs This work 
pRM21 pKOR1 orfX SNPs This work 
pRM23 pKOR1 ΔTn554 This work 
pRM24 pET30a attL::tetM This work 
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pRM25 pKOR1 attL::tetM This work 
pRM27 pGO400::MR14 SCCmec This work 
 
Table 1.  Bacterial strains and plasmids used in this study 
1 The following strains were provided by the Network on Antimicrobial Resistance in 
Staphylococcus aureus (NARSA) for distribution by BEI Resources, NIAID, NIH 
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Primer 
Name 
Sequence 5’ to 3’ 
 
Target 
MDR85 GGGGACAAGTTTGTACAAA
AAAGCAGGCTAGGTGCCGA
AGCTCTG 
Left flank for Δ15.4kb in J region 
using pKOR1 (with attB1) 
MDR86 CCGGAATTCTAGGGGTTCA
GTGCCTATCG 
Left flank for Δ15.4kb in J region 
using pKOR1 (with EcoRI) 
MDR87 CCGGAATTCATCTGATAAG
GCTACGAACAG 
Right flank for Δ15.4kb in J region 
using pKOR1 (with EcoRI) 
MDR88 GGGGACCACTTTGTACAAG
AAAGCTGGGTTGAGTCTCG
CAAATTGTCAG 
Right flank for Δ15.4kb in J region 
using pKOR1 (with attB2) 
MDR147 TGGATAGACGTCATATGAA
GGTGTGC 
mecA 
MDR148 TGGGTACAAGATGATACCT
TCGTTCCAC 
mecA 
MDR151 TGCTCGAGTGCGGCCGCTG
GACCGAATGGACTAGCAC 
Left flank for ΔmecA-
ψIS1272::tetM; for pET30a cloning 
using NotI and InFusion 
MDR152 GTAAGAGCATATTTGAGTG
AAGCAATCCGTAACGATG
G 
Left flank for ΔmecA-
ψIS1272::tetM; for pET30a cloning 
using InFusion 
MDR153
  
CAAATATGCTCTTACGTGC 
 
TetM for ΔmecA-ψIS1272::tetM; 
for pET30a cloning using InFusion 
MDR154 ACTTCGTACCATCCTAAATA
TTGAAGGCTAGTCAG 
TetM for ΔmecA-ψIS1272::tetM; 
for pET30a cloning using InFusion 
MDR155 AGGATGGTACGAAGTTGC
ACCACG 
Right flank for ΔmecA-
ψIS1272::tetM ; for pET30a cloning 
using InFusion 
MDR156 GCTGATATCGGATCCACAC
AGAAGCCATATTTAGCGAT
GATG 
Right flank forΔmecA-
ψIS1272::tetM; for pET30a cloning 
using BamHI and InFusion 
MDR157 GGGGACAAGTTTGTACAAA
AAAGCAGGCTTGGACCGAA
TGGACTAGCAC 
Insert from pRM11 for ΔmecA-
ψIS1272::tetM; has attB1 for 
pKOR1 
MDR158 GGGGACCACTTTGTACAAG
AAAGCTGGGTACACAGAAG
CCATATTTAGCGATGATG 
Insert from pRM11 for ΔmecA-
ψIS1272::tetM; has attB2 for 
pKOR1 
MDR213 GGCCGGATCCTAGCGCATA
GAGGAACTGTTAGTAG 
orfX region for mutating SNPs in 
450MEX; with BamHI for pUC19 
MDR214 GGCCGAATTCTTGAGTTCG
GAAGATAAAGTTAATGCTC 
orfX region for mutating SNPs in 
450MEX; with EcoRI for pUC19 
MDR215 TGGAAGCAGGCCATAGCTGAATATG 
Around the horn on pRM19 to 
introduce 2 SNPs (bold) in orfX 
MDR216 CATATTCAGCTATGGCCTGC Around the horn on pRM19 to 
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TTCCA introduce 2 SNPs in orfX 
MDR221 GGGGACAAGTTTGTACAAA
AAAGCAGGCTTAGCGCATA
GAGGAACTGTTAGTAG 
Mutated orfX insert from pRM20; 
has attB1 for pKOR1 
MDR222 GGGGACCACTTTGTACAAG
AAAGCTGGGTTTGAGTTCG
GAAGATAAAGTTAATGCTC 
Mutated orfX insert pRM20; has 
attB2 for pKOR1 
MDR285a TGCTCGAGTGCGGCCGCTG
AAAGCAAGACAATTAGTG
AGC 
Left flank for inserting tetM 
downstream attL; InFusion cloning 
into pET30a with NotI 
MDR286a GATTTTCCTCCATTC 
TTAGTTTTACTTATGATAC
GCC 
Left flank for inserting tetM 
downstream attL; InFusion cloning 
into pET30a 
MDR287a GAATGGAGGAAAATCACA
TGAAAATTATTAATATTGG 
tetM for inserting tetM downstream 
attL; InFusion cloning into pET30a 
MDR288a CTCATACAGAATTTTACGAT
CTCCTCCTTTCCAC 
tetM for inserting tetM downstream 
attL; InFusion cloning into pET30a 
MDR289a AAAATTCTGTATGAGGAGA
TAATAATTTGG 
Right flank for inserting tetM 
downstream attL; InFusion cloning 
into pET30a 
MDR290a GCTGATATCGGATCCAAGA
TTCTGAAGGTCTAACGTAA
TC 
Right flank for inserting tetM 
downstream attL; InFusion cloning 
into pET30a with BamHI 
MDR291a GGGGACAAGTTTGTACAAA
AAAGCAGGCTTGAAAGCAA
GACAATTAGTGAGC 
Insert from pRM24 for inserting 
tetM downstream attL; using 
pKOR1with attB1 
MDR292a GGGGACCACTTTGTACAAG
AAAGCTGGGTAAGATTCTG
AAGGTCTAACGTAATC 
Insert from pRM24 for inserting 
tetM downstream attL; using 
pKOR1with attB1 
MDR311 TGAAACAGCAGCTAGAGT
GC 
Right SCCmec integrated junction; 
fwd 
MDR312 ATGTCCTGGCGTGTCTATG
ATG 
Right SCCmec integrated junction; 
rev 
cR1 AAGAATTGAACCAACGCAT
GA 
Left SCCmec integrated junction; 
fwd 
cR2 AAACGACATGAAAATCACC
AT 
Left SCCmec integrated junction; 
fwd 
mR8 ATGAAAGACTGCGGAGGC
TAACT 
Left SCCmec integrated junction; 
rev 
mL1 GAATCTTCAGCATGTGATT
TA 
Right SCCmec integrated junction; 
fwd 
cL1 ATTTAATGTCCACCATTTA
ACA 
Right SCCmec integrated junction; 
rev 
colA GTTCCCAGTAGCAACCTTC
C 
Left SCCmec integrated junction; 
rev 
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colB CAATGAAAGCTTGGAAGA
AGGGC 
Right SCCmec integrated junction; 
fwd 
8325_ 
0042F 
TGCGATTGTTAATGGGATA
GG 
ORF0042 
8325_ 
0042R 
TGCACATAATCCTCCAATG
C 
ORF0042 
ermAfwd TGATGGAGGCTTATGTCAA
GTG 
ermA 
ermArev TTCAAAGCCTGTCGGAATT
G 
ermA 
MupProbe
Fwd 
TCCTCATGCTGGCCATGTT
C 
mupirocin resistance gene 
MupProbe
Rev 
AACGCAGTCATTATCTTCA
CTGAGTTG 
mupirocin resistance gene 
MecProbe
Fwd 
TGGCCAATACAGGAACAG
C 
mecA 
MecProbe
Rev 
TGGCATTGTAGCTAGCCAT
TCC 
mecA 
 
Table 2.  Primers used in this study 
 
Sequence in bold = annealing sequence 
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CHAPTER 3 
 
 
Results: 
 
Excision of SCCmec 
 
 
 
 As previously mentioned, site-specific excision and integration of SCCmec is 
catalyzed by the Ccr recombinases, CcrA and CcrB, encoded within the element (70, 71), 
and the recombinases from one SCCmec type can act on and excise other SCCmec types 
(85).  Also mentioned, ccrAB overexpression from a multicopy plasmid results in high 
frequency excision (84, 85).  The plasmid pWA46 used in these studies expressed ccrAB 
gene complex type II under the control of a cadmium-inducible promoter so that in the 
presence of inducer (cadmium) ccrAB was overexpressed, and resulting in high frequency 
excision.  In the absence of a plasmid driving excision, ccrAB is expressed from its own 
SCCmec element and results in very low spontaneous excision frequencies (10-5 to 10-6) 
(166).  Therefore, SCCmec excision is either referred to as induced or spontaneous.  
Characterizing excision is the first step in understanding how SCCmec is transferred 
among staphylococci.   
Inducible excision frequencies were determined over three days for S. aureus 
N315 SCCmec type II and 450M SCCmec type I using pWA46 in the presence and 
absence of cadmium induction. SCCmec elements also frequently harbor plasmids and 
transposons that often encode additional resistance factors; these resistance markers were 
used for excision screening purposes.  Specifically, plasmid pUB110 is integrated in 
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N315 SCCmec type II and includes a gene that encodes kanamycin resistance.   SCCmec 
type I in 450M was genetically manipulated to carry an internal tetracycline marker 
(tetM) to generate strain MR4.  Over three days, ccrAB-mediated inducible excision was 
monitored in the presence and absence of cadmium induction by screening for loss of the 
resistance phenotype.  Each culture of S. aureus N315 or S. aureus MR4 started from a 
single colony grown in TSB with or without cadmium chloride (5 µM), and a 1:1000 
dilution was done using the same conditions for the following day up to three days.  Each 
day, serial dilutions of the bacterial cultures were prepared and plated on TSA plates with 
or without cadmium chloride (5 µM), and the next day over 100 individual colonies from 
each strain grown in both the presence and absence of cadmium induction were plated to 
either TSA plates with kanamycin (20 µg/ml) or tetracycline (10 µg/ml) to screen for loss 
of resistance.  Figure 1 shows the results of S. aureus N315 SCCmec type II inducible 
excision, and Figure 2 shows the results of S. aureus MR4 SCCmec type I inducible 
excision.   After three days, inducible excision of S. aureus N315 SCCmec type II was 
88.5% (88.5% of colonies screened were kanamycin sensitive) whereas S. aureus MR4 
SCCmec type I inducible excision was 29.0%.  
 In these experiments, as stated above, ccr gene complex type II was 
overexpressed to induce SCCmec excision.  Even though CcrAB from one SCCmec type 
can act on and excise other SCCmec types (85), differences among types may account for 
variable excision frequencies.  This could potentially explain why inducible excision for 
SCCmec type I was only 29.0% after three days following induction with a type II ccr 
gene complex.  
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Figure 1.  S. aureus N315 pWA46 SCCmec Type II Inducible Excision 
   
N315 SCCmec type II contains a gene that encodes kanamycin resistance. pWA46 
expresses ccrAB under the control of a cadmium-inducible promoter.  Excision was 
monitored by screening for loss of kanamycin resistance for three days in the presence or 
absence of cadmium induction (5 µM cadmium chloride).  At day 3, inducible excision of 
N315 SCCmec was 88.5% (88.5% of colonies screened were kanamycin sensitive) and in 
the absence of cadmium induction excision was 4%. 
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Figure 2.  S. aureus MR4 pWA46 SCCmec Type I Inducible Excision 
MR4 SCCmec type I carries a gene that encodes tetracycline resistance.  pWA46 
expresses ccrAB under the control of a cadmium-inducible promoter. Excision was 
monitored by screening for loss of tetracycline resistance for three days in the presence or 
absence of cadmium induction (5 µM cadmium chloride).  At day 3, inducible excision of 
MR4 SCCmec was 29.0% (29.0% of colonies screened were tetracycline sensitive) and in 
the absence of cadmium induction excision was not detected. 
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In addition, data from Figures 1 and 2 also show that in the absence of inducer, 
SCCmec excision frequencies were low or not observed: 4% by day three for N315 and 
0% for MR4.   As previously mentioned, spontaneous SCCmec excision frequencies are 
10-5 to 10-6 (166).  The 4% excision frequency detected for N315 in the absence of 
inducer could be attributed to the fact that the cadmium-inducible promoter is not tightly 
regulated, and so ccrAB is likely being expressed more than expected.   
To provide a tool for monitoring excision without relying on negative phenotype 
(the absence of resistance) screening techniques for such a low frequency event, a strain 
was created that allowed positive selection for excision (MR14) (Figure 3).  To positively 
select for excision in S. aureus N315 SCCmec type II, a promoterless gene encoding 
tetracycline resistance (tetM) was inserted immediately downstream of SCCmec attL.  
When SCCmec is excised, tetM expression would be driven by the orfX promoter.  In 
addition, it was necessary to remove 15.4kb of DNA in the SCCmec J region immediately 
5’ to the promoterless tetM gene because promoter activity in this region was generating 
tetracycline resistance in the absence of SCCmec excision.  This reduced the total size of 
the SCCmec element in MR14 from 53kb in the intact N315 SCCmec element to 30.8kb. 
Transposon Tn554 was also deleted, which was important when investigating intact 
SCCmec transfer via transduction and conjugation (discussed in subsequent chapters) to 
avoid transposable mechanisms of gene transfer.  
After the creation of MR14, it was important to make sure SCCmec excised at a 
similar frequency to intact N315 SCCmec.  To test this, pWA46 was introduced into 
MR14 and a single colony was grown overnight in the presence and absence of cadmium  
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Figure 3.  The creation of MR14 for positive selection for excision 
S. aureus N315 SCCmec (53 kb) was modified to allow positive selection for excision. 
The resulting strain is MR14.  A promoterless gene encoding tetracycline resistance 
(tetM) was cloned immediately downstream of SCCmec attL.  15.4kb of DNA upstream 
of tetM was deleted to remove promoter activity in this region that was generating 
tetracycline resistance in the absence of excision.  The Tn554 region (6.7 kb) was also 
deleted. The resulting size of MR14 is 30.8 kb.  Cells with integrated SCCmec are 
tetracycline sensitive and kanamycin resistant.  Excised cells (MR14EX) express tetM 
from the orfX promoter and are tetracycline resistant and kanamycin sensitive.  
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induction.  The resulting cultures were plated on TSA and TSA with tetracycline (10 
µg/ml) and colonies were counted the next day.  Tetracycline resistant colonies were also 
plated on TSA kanamycin (20 µg/ml) to confirm sensitivity and thus excision.  After one 
day, in the presence of cadmium induction, 7.0x107 CFU/ml were tetracycline resistant 
and total cell growth on TSA was 2.5x108 CFU/ml, or in other words 28.0% (TET/TSA x 
100) of the total population had excised SCCmec.  In the absence of cadmium induction, 
8.0x106 CFU/ml were tetracycline resistant and total cell growth on TSA was 4.0x108 
CFU/ml meaning that 2.0% of the total population excised SCCmec in the absence of 
cadmium induction.  Figure 4 expresses the data as a percentage of tetracycline growth 
relative to growth on TSA (total population) in order to show that MR14 inducible 
excision at day one (28.0%) determined by positive selection is comparable to excision 
results determined by screening for loss of SCCmec as shown in Figure 1, which was 
20.5% at day one.   
MR14 was also used to determine the frequency of spontaneous excision by 
plating serial dilutions of an overnight culture on TSA and TSA with tetracycline 
(10µg/ml).  Figure 5 shows the total bacterial counts, and the frequency of spontaneous 
excision (excised population/total population) is 1.16x10-6.  It was hypothesized that 
spontaneous excision frequencies during infection may be greater than 10-6 since ccrAB 
expression had been reported to increase under stressful conditions (92) and transfer of 
SCCmec has been observed during colonization and infection on multiple occasions (89-
91).  Therefore, MR14 spontaneous excision was also determined using a rabbit infective 
endocarditis model (see Materials and Methods).  Eight rabbits total had an average of 
4.92x108 CFU/g tissue, and an average of 3.32x102 CFU/g tissue grew in the presence of 
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Figure 4.  S. aureus MR14 pWA46 Inducible Excision at Day 1	  
 
MR14 SCCmec inducible excision was monitored by positive selection on tetracycline.  
pWA46 expresses ccrAB under the control of a cadmium-inducible promoter. In the 
presence or absence of cadmium induction (5µM cadmium chloride), excision 
percentages were determined by plating overnight cultures on TSA and TSA with 
tetracycline.  and comparing growth on tetracycline to total growth without antibiotic 
selection.  MR14 SCCmec inducible excision at day one was 28.0% and in the absence of 
inducer was 2.0%. 
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Figure 5.  S. aureus MR14 Spontaneous Excision 
MR14 spontaneous excision in vitro was determined by plating serial dilutions of an 
overnight culture on TSA and TSA with tetracycline. An average of 4.93x108 CFU/ml 
grew on TSA representing the total population.  An average of 5.70x102 CFU/ml grew on 
TSA with tetracycline representing the excised population. The frequency of spontaneous 
excision (excised population/total population) was calculated to be 1.16x10-6.   
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tetracycline (Figure 6).  The frequency of spontaneous excision was determined to be 
5.02x10-7 (excised population/total population) and was, thus, similar to the spontaneous 
excision rate measured under laboratory culture conditions. 
As previously mentioned, when SCCmec is integrated in the chromosome attR 
and attL flank the element on the left and right end, respectively.  When SCCmec excises 
it forms a non-replicating circular intermediate harboring the reconstituted attS site and 
leaves the reconstituted attB site within orfX on the chromosome (70, 71).  Using the 
differences in sequences across these four att-site junctions, a polymerase chain reaction 
(PCR) based approach could also be used to monitor excision and integration of SCCmec 
as wells as the presence of the excised SCCmec circular element (Figure 7).  Figure 8 
shows that a typical MR14 bacterial culture undergoing spontaneous excision has a 
mixed population of integrated, excised, and circular SCCmec products, thus 
demonstrating the dynamic process of excision and integration within a population.  On 
the other hand, a completely excised population, designated as MR14EX, only had the 
excised chromosomal junction, and, importantly, the circular non-replicating SCCmec 
intermediate had been lost. 
Results in this chapter differentiate between induced and spontaneous excision by 
the drastic difference in excision frequencies.  Based on the observation that SCCmec 
type II in combination with overexpression of its paired ccr gene complex type II led to 
the highest inducible excision frequency, this combination was chosen for further studies 
to induce SCCmec excision when attempting to mobilize SCCmec.  The construction of a 
positive selection strain (MR14) for spontaneous excision aids in monitoring excision 
that would otherwise rely on screening for an event that has a low frequency of 10-6.  This 
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Figure 6.  MR14 spontaneous excision using a rabbit infective endocarditis model 
 
MR14 spontaneous excision was also determined using a rabbit infective endocarditis 
model.  Eight rabbits total had an average of 4.92x108 CFU/g tissue in their heart 
vegetations. Where an average of 3.32x102 CFU/g tissue grew in the presence of 
tetracycline. Excision was not detected in four of the rabbits. The frequency of 
spontaneous excision was determined to be 5.02x10-7 (excised population/total 
population). 
This graph was made using GraphPad Prism 6. 
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Figure 7.  Diagram of PCR based approach to determine excision and integration of 
SCCmec 
 
A combination of four primers designed for each strain were used to amplify products by 
PCR to determine the presence of integrated, excised, and circular SCCmec. Primers used 
for each strain are included in the primer list in Table 2.  
Integration of SCCmec-  
1. Left integrated chromosomal junction amplified using a forward primer upstream of 
attR (maroon) and a reverse primer downstream of attR internal to SCCmec (green).   
2. Right integrated chromosomal junction amplified using a forward primer internal to 
SCCmec upstream of attL (green) and a reverse primer downstream of attL (maroon).  
Excision of SCCmec-  
3. Excised chromosomal junction amplified by the forward primer upstream of attR               
(maroon) and the reverse primer downstream of attL (maroon).  
4. Circular SCCmec junction amplified by the primers internal to SCCmec (green) would 
be able to amplify the excised circular SCCmec junction following excision and 
circularization of SCCmec. 
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Figure 8.  Amplification of SCCmec integrated and excised junctions in MR14 and 
MR14EX 
 
Lane A. NEB 1 kb ladder; Lane B. NEB 100 bp ladder; Lane 1. Left integrated 
chromosomal junction (primers: cR1/mR8);  Lane 2. Right integrated chromosomal 
junction (primers: MDR311/MDR312); Lane 3. Excised chromosomal junction (primers: 
cR1/MDR312); Lane 4. Circular SCCmec junction (primers: mR8/MDR311) 
In the first panel, DNA from a MR14 bacterial culture has a mixed population of 
integrated, excised, and circular SCCmec products. Shown in the middle panel, a 
completely excised population, designated as MR14EX, only had the excised 
chromosomal junction, and the circular SCCmec following excision had been lost. 
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model confirmed that the spontaneous excision frequency of SCCmec is 10-6 by simply 
selecting for cells that grow in the presence of tetracycline.  The consistent low frequency 
of spontaneous excision that is seen both laboratory culture and in a rabbit infective 
endocarditis model likely correlates to the bistability phenotype described previously (94) 
and, although low, is assumed to be advantageous for the overall population because only 
a few cells in the MRSA population lose their SCCmec element to become methicillin 
susceptible and thus sacrifice themselves in order to transfer SCCmec into new recipient 
strains.  It is also important to note that although integration and excision are dynamic 
within the entire population, an excised (EX) cell will lose all integrated SCCmec as well 
as the circular SCCmec intermediate, as shown by PCR results.  This has significant 
implications when investigating transfer of the element because the circular intermediate 
would require a mechanism of capture and transfer before it is lost completely. 
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CHAPTER 4 
 
 
Results: 
 
SCCmec mobilization via bacteriophage 
 
 
 
Transduction of SCCmec was the first mechanism of transfer tested.  Based on the 
previously mentioned data that mecA was found in a variety of environmental phage 
isolate samples (133-135), and the abundance of bacteriophage in the environment, 
transduction was deemed a probable mechanism of SCCmec transfer.  Collaboration with 
undergraduate students from James Madison University also found mecA gene products 
by PCR from various phage samples isolated from different environmental sources in 
Harrisonburg, Virginia (data not shown).  Additional attempts to characterize the 
presence of mecA and SCCmec in these phages were not successful, but results were 
compelling enough to test the possibility of SCCmec transduction in vitro. 
To assess the ability of phage to transduce SCCmec, an optimized donor strain 
was first constructed.  The first consideration was the size of SCCmec since, as 
mentioned previously, transducing phage encapsidate DNA commensurate to the size of 
the phage genome (131, 132), and staphylococcal bacteriophage 80α used here has a 
genome size of 43.9 kb.  While N315 SCCmec type II would have been ideal due to its 
high frequency excision, it is also one of the largest SCCmec elements (53 kb) and would 
not be able to be packaged fully intact by bacteriophage 80α.  Furthermore, N315 
contains prophages that interfered with bacteriophage 80α infection, so N315 was not 
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considered an ideal donor.  Therefore, strains with SCCmec type I (34.3 kb) and SCCmec 
type IV (24.1 kb) were next considered as donor candidates based on their small sizes.  
The next consideration was the ability of bacteriophage 80α to infect and produce 
high phage titers from the donor strain to maximize the number of phage particles 
produced and thus the probability of encapsidated SCCmec.  80α phage lysates were 
prepared from strains MW2 (SCCmec type IV), COL (SCCmec type I), 450M (SCCmec 
type I), and RN4220 as a control and titers were determined by plating on an indicator 
strain (RN4220).  Results in Figure 9 show that 450M (SCCmec type I) produced the 
largest phage titer, 1011 PFU/ml, so it was chosen as the donor strain in SCCmec 
transduction experiments.  SCCmec type IV was ruled out as a transduction candidate 
because the strain harboring this type, MW2, was determined to have prophages that 
interfered with bacteriophage 80α resulting in a low phage titer.   
In order to select for transfer of SCCmec into a recipient strain, an antibiotic 
resistance marker within SCCmec was needed.  The 450M derivative MR4, which 
replaced the mec complex with the gene tetM encoding for tetracycline resistance was 
used.  The genetic manipulations of deleting the mec region and adding tetM reduced the 
size of the SCCmec element from 34.3 kb to 32.0 kb which, theroretically, could be 
packaged by bacteriophage 80α.  Important for transfer experiments, the type I mec 
complex, which has unregulated mecA, had been deleted so that any transfer of SCCmec 
type I into a recipient would be enhanced because the cells would not have to adapt to 
unregulated mecA expression which is usually a restrictive barrier as noted before (125). 
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Figure 9.  S. aureus 80α Phage Titers from Select Strains 
 
80α phage lysates were prepared from strains MW2 (SCCmec type IV), COL (SCCmec 
type I), 450M (SCCmec type I), and RN4220 as a control and titers were determined by 
plating on an indicator strain (RN4220) and calculating the number of PFU/ml. 	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There were three possible mechanisms considered for phage transfer of SCCmec.  
First would be the transfer of the chromosomal copy packaged by phage as a fragment 
with flanking homology.  Second would be the transfer of the circular element itself.  
This would be unlikely unless the element replicated, which is thought not to occur but 
has not been formally excluded.  Alternatively, SCCmec could recombine with a small, 
replicating plasmid if there were areas of homology between SCCmec and the plasmid.  
In order to test these hypotheses, high frequency excision of SCCmec in MR4 was driven 
as discussed above by overexpression of ccrAB encoded on pWA46.  Although the 
frequency of inducible excision is not as high as desired it is still a great deal higher than 
spontaneous excision and reason enough to use this approach.  While results from 
Chapter 3 may suggest that it would be better to induce excision with expression of a type 
I ccr gene complex, this type of complex has a deletion in ccrB resulting in a truncated, 
non-functional protein, and so inducing with type II ccr gene complex was the best 
available approach for driving SCCmec excision in MR4.  It was hypothesized that by 
driving excision of SCCmec there may be a increased probability of packaging SCCmec 
elements within the phage. 
After infecting the donor strain with bacteriophage 80α and obtaining a lysate, 
PCR was performed to determine what products were present in the encapsidated phage, 
and thus potentially able to be transduced (Figure 10).  Results indicated that the phage 
had packaged a mixed population of integrated, excised, and circular SCCmec. It was 
interesting that the presence of the circular SCCmec element was detected.  As noted 
above, since the circular SCCmec intermediate does not replicate it is unclear how 
fragments with this junction were packaged into transducing particles.  It is possible that 
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Figure 10.  80α virions following MR4 pWA46 infection contain integrated, excised, 
and circular SCCmec junctions 
 
Lane A. NEB 1 kb ladder; Lane 1. Left integrated chromosomal junction (primers: 
cR2/colA);  Lane 2. Right integrated chromosomal junction (primers: colB/cL1); Lane 3. 
Excised chromosomal junction (primers: cR2/cL1); Lane 4. Circular SCCmec junction 
(primers: colA/colB).   
80α was used to prepare a transducing lysate from MR4 pWA46.  Phage particles were 
purified by PEG precipitation (see Materials and Methods), DNaseI treated to remove 
any DNA that was not packaged in the phage capsids, and then subjected to 
phenol:chloroform DNA extraction.  All four junctions were present demonstrating that a 
mixed population of integrated and excised products were encapsidated in the phage, 
including the excised circular SCCmec junction.   
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circular SCCmec recombined with the small pWA46 plasmid via recombination at ccrAB 
and was packaged with pWA46.  Using the PCR approach, it is inconclusive how much 
of the SCCmec element was present in the phage capsids.   
To determine if an intact SCCmec element was present in the phage and able to be 
transferred, a transduction experiment was performed using an isogenic recipient strain, 
450MEX, which had been passaged to become resistant to rifampin and novobiocin.  The 
recipient strain also had a plasmid expressing ccrAB from S. aureus MW2, because 
previous studies had shown that CcrAB from MW2 favored integration of SCCmec over 
excision  (71).  Thus, any SCCmec transferred via phage into the recipient would likely 
be favored to integrate into the chromosome.  Important for selection purposes, the donor 
strain, MR4 pWA46, was resistant to tetracycline (encoded within SCCmec) and 
chloramphenicol (plasmid encoded), and the recipient strain was resistant to rifampin, 
novobiocin (chromosomal markers), and chloramphenicol (plasmid encoded). It is 
important to note that the donor strain was confirmed to be sensitive to rifampin and 
novobiocin while the recipient strain was sensitive to tetracycline. SCCmec transductants 
were selected on tetracycline, rifampin, novobiocin, and chloramphenicol.  The 
transduction experiment was repeated many times, using bacteriophage 80α, and always 
resulted in a single transductant.  Thus, the frequency of SCCmec transfer via phage was 
very low.  The PCR based approach discussed in Chapter 3 was used to confirm transfer 
and integration of SCCmec into the chromosome of the recipient (Figure 11).  The donor 
strain was positive for all four junctions as expected, the recipient strain was only 
positive for the excised junction, and the transductant only had chromosomal integrated 
junctions.  These results confirmed that intact, modified SCCmec type I had transferred   
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Figure 11.  PCR confirms MR4 SCCmec was mobilized by 80α and integrated into 
the recipient chromosome 
 
Lane A. NEB 1 kb ladder; Lane 1. Left integrated chromosomal junction (primers: 
cR2/colA);  Lane 2. Right integrated chromosomal junction (primers: colB/cL1); Lane 3. 
Excised chromosomal junction (primers: cR2/cL1); Lane 4. Circular SCCmec junction 
(primers: colA/colB).  Donor: MR4 pWA46; Recipient (isogenic): 450MEX pWA43; 
Transconjugant: 450MEX::SCCmec pWA43.  Donor contained a mixed population of 
junctions as expected. Recipient was only positive for the excised chromosomal junction. 
The transconjugant was only positive for products indicating SCCmec chromosomal 
integration. 
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via phage 80α into an isogenic recipient and integrated in the host chromosome.  A mixed 
population of all four junctions is likely not seen in the transductant due to the presence 
of plasmid-encoded MW2 type IV ccrAB, which drives integration (71).  These results 
were obtained at the same time as a report published by Scharn et al. that demonstrated 
SCCmec types I and IV could be mobilized into recipient strains by staphylococcal 
transducing phages Φ11 and 29 (136). 
To determine if SCCmec integrated into the recipient chromosome via att-site 
specific recombination mediated by CcrAB or by homologous recombination with the 
chromosome, as is typically seen with generalized transduction, two silent single 
nucleotide polymorphisms (SNPs) were introduced in the recipient chromosome 
upstream of attB to make strain MR10, and the transduction experiment was repeated.  If 
CcrAB mediated an att-site specific integration in the recipient then the SNPs would be 
retained, and if homologous recombination with the chromosome flanking the att site 
occurred then the SNPs would be replaced with the donor genotype.  The resulting 
transductant was sequenced and the SNPs were replaced with the wild-type genotype.  
Therefore, transduction of SCCmec type I via phage 80α had occurred by generalized 
transduction and homologous recombination in the recipient chromosome and, therefore, 
not by CcrAB mediated att-site specific integration.  
These results, in addition to similar results published at the same time of these 
findings, are not surprising (136). SCCmec types I (34.3 kb) and IV (24.1 kb) are the 
smallest of SCCmec elements, and thus would be expected to transduce via the 
transducing phages used in these studies.  However, this does not explain how the larger 
SCCmec elements may be transferred, since they are too large to package into 
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transducing particles.  In results presented here, the apparent presence of the circular 
element in the encapsidated 80α phage particles led to the hypothesis that excised circular 
SCCmec element could be packaged and transferred.  However, it is assumed that the 
circular SCCmec intermediate is non-replicating, and phage 80α is known to package 
plasmid DNA from replicating concatemers via the rolling circle mechanism of 
replication.  Therefore, it is more likely that the circular SCCmec element recombined 
with ccrAB on the pWA46 plasmid and was packaged as a single recombinant.  It would 
be interesting to delete ccrAB from the chromosomal SCCmec element and perform this 
experiment again to test this hypothesis and see if there is a loss of circular element in the 
encapsidated phage, to gain further knowledge on how the circular element may have 
been packaged.   
An important consideration, as mentioned previously, is that phages are generally 
assumed to be highly species specific with a narrow host range (126, 137).  However, the 
identical SCCmec element exists in S. epidermidis as in S. aureus. Recent findings 
showed that staphylococcal phages were able to transfer SaPI mobile elements across 
species (138, 176-179).  This is important and potentially widens the host range of phages 
previously thought to be restricted.  Therefore, it is possible that the frequency of 
SCCmec transfer via phage in the environment is higher than previously believed, and 
furthermore it is possible that larger SCCmec elements may be packaged and transferred 
via larger phages that have yet to be isolated and characterized.  Transduction 
experiments in this chapter confirmed that SCCmec type I is capable of being transferred 
via generalized transduction and homologous recombination in the recipient strain, and 
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could serve as a potential mechanism for SCCmec transfer in the environment when 
conditions are ideal.   
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CHAPTER 5 
 
 
Results: 
 
SCCmec capture on a conjugative plasmid 
 
 
 
 Because bacterial conjugation has the broadest host range among mechanisms for 
horizontal gene transfer it is considered a favorable mechanism for SCCmec transfer and 
was therefore tested as well.  As mentioned previously, pGO1 was the first Gram-positive 
staphylococcal conjugative plasmid subjected to intense genetic analysis to understand its 
mechanism of conjugative transfer (155, 165).  One specific derivative of pGO1 is the 
well-characterized conjugative plasmid pGO400.  It is 34 kb and acquired mupirocin 
resistance and lost genes encoding resistance to gentamicin, neomycin, and trimethoprim 
via recombination at IS elements (164).  The finding of multiple pGO1 derivatives with 
similar characteristics demonstrates the importance of IS elements because they could 
very well serve as a mechanism for the mobility of other staphylococcal resistance genes, 
particularly SCCmec.  
 The conjugative plasmid pGO400 was chosen for conjugation experiments based 
on its small size, the presence of three IS431/IS257 elements, and a gene encoding 
mupirocin resistance for selection.  Since all SCCmec elements contain a copy of IS431 
within the mec complex, it was postulated that, following inducible excision of the 
SCCmec element, the resulting excised circular element harboring the IS431 element 
would recombine with one of the IS431/IS257 elements on pGO400 and be captured for 
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mobilization.  To maximize excision, as discussed in Chapter 3, the modified N315 
SCCmec type II strain MR14 with plasmid pWA46 overexpressing ccrAB and containing 
pGO400 was used as the donor.  To select for any potential captured SCCmec on 
pGO400, the strain was passaged for nine days in the presence of cadmium and 
tetracycline to continually drive ccrAB expression for high frequency excision of the 
element and to positively select for cells that had excised SCCmec from the chromosome, 
respectively.  After nine days, kanamycin was introduced to select for persistence of 
SCCmec, and potential captured candidates were selected on chloramphenicol (pWA46 
resistance marker), tetracycline (positive selection for excised SCCmec on the 
chromosome), mupirocin (pGO400 resistance marker), and kanamycin (SCCmec 
resistance marker).  The kanamycin selection pressure was increased from the normal 20 
µg/ml to 100 µg/ml to avoid any potential break-through kanamycin resistant colonies.  
The concentration of kanamycin was tested on a wild-type strain (N315) expressing 
kanamycin with the same resistance gene and no growth defects were seen compared to 
growth without antibiotic selection. As shown previously in Chapter 3, the SCCmec 
circular element is lost over time and thus the kanamycin resistance phenotype would be 
lost unless the element was captured on the plasmid replicon.  Following the nine days of 
passage in the absence of kanamycin, any colonies that grew in the presence of 
kanamycin and tetracycline were evaluated as potential candidates for excised 
chromosomal SCCmec that had been captured on pGO400.  There was an average of 
7.5x101 CFU/ml from five replicates that grew with kanamycin, tetracycline, mupirocin, 
and chlorampenicol.  Based on the total number of cells in the population (8.7x108 
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CFU/ml), the apparent capture frequency was 8.6x10-8 (number of candidates/total 
population). 
 To test if SCCmec was truly captured on pGO400 in these candidates, a 
conjugative filter mating was performed to see if the suspected recombinant plasmid 
could be transferred into a recipient strain.  Figure 12 diagrams the initial transfers of 
pGO400 with captured SCCmec, and this plasmid is now referred to as pRM27.  The first 
donor was the potential captured strain, MR14 pWA46 pRM27, and the recipient was 
N315EX that was passaged to become resistant to rifampin and novobiocin.  
Transconjugants were selected on mupirocin, kanamycin, rifampin, and novobiocin and 
confirmed to be sensitive to tetracycline and chloramphenicol (donor resistance 
phenotypes).  These transconjugants then became the donor for conjugative filter mating 
into a new recipient, RN4220 pCN36 (empty vector providing tetracycline resistance 
selection), and resulting transconjugants were selected on mupirocin, kanamycin, and 
tetracycline and confirmed to be sensitive to rifampin and novobiocin (donor resistance 
phenotypes). Figures 13 and 14 show the total number of donors, recipients, and 
transconjugants for each transfer.  Conjugation frequencies were determined by dividing 
the number of transconjugants by the number of donors.  From MR14 pWA46 pRM27 
into N315EX, the pRM27 conjugation frequency was 9.09x10-8. Then, from N315EX 
pRM27 into RN4220 pCN36, the conjugation frequency was 4.08x10-9.  In addition, 
N315EX pRM27 and RN4220 pCN36 pRM27 were streaked on plates containing 
oxacillin and mecA was amplified by PCR to confirm the expression and presence of this 
critical gene.  Interestingly, mecA expression was a heterotypic, discussed previously, in 
 
	   71	  
 
 
 
 
Figure 12. Diagram depicting the first characterized conjugative transfer of 
SCCmec 
 
Shown here for simplicity is a flow chart of initial conjugative transfer passages.  Each 
strain became a donor to the recipient listed immediately below it.  These transfer events 
were the first to characterize MR14 SCCmec capture on pGO400 and its mobilization 
into an isogenic background following by movement into a heterologous host discussed 
in figures to follow. Resistant markers are noted that were used for selection.  Kan: 
kanamycin, Tet: tetracycline, Mup: mupirocin, Chl: chloramphenicol, Rif: rifampin, Nov: 
novobiocin. Kan and Mup are markers located on the plasmid pRM27 
(pG0400::SCCmec). 
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Figure 13.  SCCmec transconjugants from conjugative filter mating from a donor to 
its isogenic recipient 
 
Conjugative filter matings were performed using equal numbers of donors and recipients. 
The donor strain was MR14 pWA46 pRM27 at 2.20x108 CFU/ml and resistant to 
kanamycin, tetracycline, chloramphenicol, and mupirocin. The recipient strain was 
N315EX at 5.50x108 CFU/ml and resistant to rifampin and novobiocin. The number of 
pRM27-containing transconjugants obtained following selection on kanamycin, 
mupirocin, rifampin, and novobiocin was 20 CFU/ml.  The conjugation frequency was 
calculated to be 9.09x10-8 (number transconjugants / number donors). 
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Figure 14.  SCCmec transconjugants from conjugative filter mating from a donor to 
a heterologous recipient 
 
Conjugative filter matings were performed using equal numbers of donors and recipients. 
The donor strain was N315EX pRM27 at 4.90x109 CFU/ml and resistant to kanamycin, 
mupirocin, rifampin, and novobiocin. The recipient strain was RN4220 pCN36 at 
4.00x108 CFU/ml and resistant to rifampin and novobiocin. The number of pRM27-
containing transconjugants obtained following selection on kanamycin, mupirocin, and 
tetracycline was 19 CFU/ml.  The conjugation frequency was calculated to be 4.08x10-9 
(number transconjugants / number donors).  
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the recipient strains even though the original donor had been passaged to be homotypic. 
PFGE was then performed using a restriction enzyme (NarI) that cut pGO400 
once and did not cut SCCmec internally, followed by Southern blot analysis using a mecA 
probe and a mupirocin probe on the original captured donor, the N315EX RifR NovR 
pRM27 transconjugant, the RN4220 pCN36 pRM27 transconjugant, and RN4220 
pGO400 as a control (Figure 15).  The expected size of empty pGO400 is 34 kb and the 
recombinant pGO400 with modified SCCmec type II from MR14 (pRM27) would be 64 
kb.  In addition, the chromosomal mecA fragment is expected to be 83 kb as predicted in 
silico.  As shown in Figure 15, a band of approximately 64 kb was seen that hybridized 
with both the mecA and the Mupirocin (MUP) probes in the RN4220 pCN36 recipient, 
consistent with the capture of SCCmec on pGO400.  However, this blot showed two 
interesting and unexpected findings.  First, in the original donor strain (MR14 pWA46 
pRM27), pGO400-captured SCCmec was not detected, as mupirocin and mecA probes 
did not co-migrate at 64 kb.  Instead, empty pGO400 vector was present with re-
integrated SCCmec in the chromosome including an extra 16 kb of DNA, increasing the 
predicted mecA fragment size from 83 kb in the original donor to 99 kb.  The extra 16 kb 
of DNA re-integrated into the original host is hypothesized to be a portion of SCCmec 
that may carry a promoter driving tetracycline resistance.  The use of tetracycline as a 
selection marker is thought to have stabilized this single re-insertion event.  In the 
absence of this selection, multiple insertions may have occurred, as was seen in the 
N315EX transconjugant and is described below.  Genomic DNA isolated from this strain 
has been submitted for whole genome sequencing to determine the nature of the extra 16 
kb.  It would be interesting to see whether multiple re-insertions would occur in the   
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Figure 15.  Southern blot confirms SCCmec is captured on conjugative plasmid 
pGO400 
 
Strains were digested using a restriction enzyme (NarI) that cut pGO400 once and did not 
cut SCCmec internally, separated via PFGE, and followed with Southern blot analysis 
using mecA and mupirocin probes. mecA probes for the SCCmec fragment and mupirocin 
probes for the conjugative plasmid, pGO400. The expected size of empty pGO400 is 34 
kb. SCCmec from MR14 is 30.8 kb.  The recombinant pGO400::SCCmec (pRM27) 
would be 64 kb.  The chromosomal mecA fragment is expected to be 83 kb.  
Lane A. MidRangeII PFG Marker (NEB); Lane 1. MR14 pWA46 pRM27; Lane 2. 
N315EX pRM27; Lane 3. RN4220 pCN36 pRM27; Lane 4. RN4220 pGO400 (empty 
vector control). 
Lanes 1 show empty pGO400 with re-integrated SCCmec in the chromosome including 
roughly an extra 16 kb of DNA (Table 3).  Lanes 2 show empty pGO400 with multiple 
insertions of SCCmec (Table 3).  Lanes 3 show captured SCCmec element on pGO400 
because mecA and MUP probes co-migrate at 64 kb.  Lane 4 is a mecA-negative pGO400 
control.  
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original donor in the absence of tetracycline, as seen with the mecA probe in an isogenic 
background in Lane 2 of Figure 15.  
The second unexpected result was that re-integration of SCCmec was also seen in 
the recipient chromosome of N315EX, which displayed a ladder of multiple sized mecA 
bands.  The sizes of these bands were determined from a standard curve based on 
distance migrated compared to known standard marker migrations (Figure 16) and are 
presented in Table 3.  Each band was larger than the one below it by approximately 30 
kb, the size of the SCCmec element.  It was hypothesized that these were multiple 
insertion events in a single colony, due to either multiple excision and insertions from the 
multicopy plasmid or insertions followed by gene duplications.  These were confirmed to 
be identical duplicated copies by digesting the DNA from this strain with a restriction 
enzyme, SacI, that cuts once within SCCmec, and probing with mecA.  As shown in 
Figure 17, this resulted in a single band, confirming the presence of multiple duplicated 
copies of SCCmec within cells in the population.  
It is important to note that the Southern blot analysis may not have been sensitive enough 
to detect pRM27 in the original donor and in the N315EX recipient because integration of 
SCCmec into the chromosome was favored in this background (discussed below).  It is 
likely that only a small population of pRM27 remained, while the majority was empty 
pGO400 in which SCCmec had recombined out to integrate in the chromosome.  This is 
supported by that fact that the original donor (MR14 pWA46 pRM27) could be 
transferred by conjugative filter mating into N315EX, forming transconjugants that were 
then able to serve as new donors into RN4220 pCN36.  This indicates that the population 
was still present but just not detectable based on the sensitivity of the Southern blot  
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Figure 16.  Standard curve to determine size of multiple SCCmec re-insertions in 
N315EX following conjugative transfer 
 
Standard curve generated by measuring band migration distance (cm) of the MidRange II 
PFG Marker fragments plotted against the known size of each band as log (kb).  A line 
equation was determined and used for extrapolating sizes of fragments seen in samples 
based on distance migrated in cm. 
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Table 3.  The distance migrated in cm for the mecA fragment detected in MR14 pWA46 
pRM27 in Lane 1 of Figure 15 and for the multiple mecA bands seen in N315EX pRM27, 
Lane 2 of Figure 15.  In MR14 pWA46 pRM27 there was determined to be an extra 16 
kb of DNA associated with the mecA expected fragment size. In N315EX pRM27, each 
band was larger than the one below it by approximately 30 kb, the size of the SCCmec 
element. 
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Figure 17.  Duplicated copies of SCCmec integrated into the N315EX chromosome 
following conjugative transfer 
 
MR14 control (Lane 1) and N315EX pRM27 (Lane 2) that had predicted multiple 
SCCmec insertions were digested with restriction enzyme SacI which cut once within 
SCCmec so that if multiple insertions of SCCmec had occurred the mecA probed 
fragments would then co-migrate as one. PFGE was then performed followed by 
Southern blot and probing with mecA. This resulted in a collapsed mecA band from the 
previous multiple insertions seen in Figure 15.  This confirmed the presence of multiple 
duplicated copies of SCCmec within cells in the population.  
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procedure. 
The Southern blot analysis discussed above confirmed SCCmec capture on the 
conjugative plasmid in recipient RN4220 pCN36 and reintegration of SCCmec into the 
original donor and an isogenic background in N315EX.  Following this analysis, a PCR 
based approach was also used to characterize SCCmec re-integration in the original 
captured donor, MR14 pWA46 pRM27.  Figure 18 shows that only the attR SCCmec 
chromosomal junction and circular SCCmec junction were amplified in the original 
captured donor.  The attL SCCmec chromosomal junction did not amplify.  This is 
hypothesized to be due to the additional 16 kb of DNA that had inserted at this site as 
discussed above, which could not be amplified with the PCR conditions used.  In 
addition, there was an absence of the excised chromosomal junction, implying that the 
cells within the population had all integrated SCCmec.  Whole genome sequencing of this 
strain will further confirm this.  Also, the circular SCCmec junction was amplified 
indicating that if circular SCCmec recombined with pGO400 via IS elements as 
hypothesized then the circular junction (attS) would be preserved on the recombinant 
conjugative plasmid.   
Figure 19 characterizes the N315EX pRM27 transconjugant. This transconjugant 
contains the integrated, excised, and circular junctions present as expected.  In addition, 
controls were included to confirm the amplification products of mupirocin, mecA, and a 
N315 specific product while also confirming the absence of a RN4220 specific product 
since RN4220 pCN36 was the next recipient. 
The same PCR approach was used to characterize the RN4220 pCN36 pRM27 
transconjugant. Specifically, results confirm that SCCmec did not integrate into this  
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Figure 18.  PCR analysis to confirm reintegrated SCCmec in MR14 pWA46 pRM27 
and preservation of the excised circular SCCmec junction 
 
Lane A. 1 kb ladder (NEB); Lane B. 100 bp (NEB); Lane 1. Left integrated chromosomal 
junction (cR1/mR8); Lane 2. Right integrated chromosomal junction (MDR311/cL1); 
Lane 3. Excised chromosomal junction (cR1/cL1); Lane 4. Excised circular SCCmec 
junction (mR8/MDR311).  
MR14 pWA46 pRM27 is the donor passaged for SCCmec capture on pGO400 and MR14 
pWA46 pGO400 is the original strain before capture.   
The original strain contains all four junctions as expected.  The bands are larger than the 
usual ~500 bp products for the left integrated chromosomal junction fragment and the 
excised chromosomal junction fragment due to the placement of the downstream attL 
which results in amplification of the tetM gene also that was inserted into MR14.  The 
passaged strain shows persistence of the circular excised SCCmec junction because if 
circular SCCmec has been captured on pGO400 via IS-mediated recombination then the 
presence of the circular junction would be preserved on the recombinant conjugative 
plasmid.  The negative result for the right integrated chromosomal junction at attL is 
likely due to the extra 16 kb associated with the SCCmec element that could not be 
amplified under the PCR conditions used.  The presence of the right integrated 
chromosomal junction at attR is positive for SCCmec integration. 
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Figure 19.  PCR analysis to characterize the N315EX pRM27 transconjugant 
 
Lane A. 1 kb ladder (NEB); Lane 1. Left integrated chromosomal junction (cR2/mR8); 
Lane 2. Right integrated chromosomal junction (MDR311/cL1); Lane 3. Excised 
chromosomal junction (cR2/cL1); Lane 4. Excised circular SCCmec junction 
(mR8/MDR311); Lane 5. mecA fragment (MDR147/MDR148); Lane 6. ORF0042 
fragment specific to RN4220 (8325_0042F/8325_0042R); Lane 7. ermA fragment from 
N315 (ermAfwd/ermArev); Lane 8. gene for mupirocin resistance 
(MupProbeFwd/MupProbeRev); Lane B. 100 bp ladder (NEB). 
The transconjugant was positive for all four junctions analyzing SCCmec integration and 
excision indicating that the recipient had received SCCmec and it was integrating and 
excising from the chromosome as expected. mecA and mupirocin gene products were also 
present. Cells were confirmed to be of N315 by amplification of ermA and the absence of 
ORF0042 fragment amplification was a control since that was the next recipient (Figure 
20). The presence of mecA and mupirocin implied conjugative transfer. 
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Figure 20.  PCR analysis to characterize the RN4220 pCN36 pRM27 transconjugant 
 
Lane A. 1 kb ladder (NEB); Lane 1. Left integrated chromosomal junction (cR2/mR8); 
Lane 2. Right integrated chromosomal junction (MDR311/cL1); Lane 3. Excised 
chromosomal junction (cR2/cL1); Lane 4. Excised circular SCCmec junction 
(mR8/MDR311); Lane 5. mecA fragment (MDR147/MDR148); Lane 6. ORF0042 
fragment specific to RN4220 (8325_0042F/8325_0042R); Lane 7. ermA fragment from 
N315 (ermAfwd/ermArev); Lane 8. gene for mupirocin resistance 
(MupProbeFwd/MupProbeRev); Lane B. 100 bp ladder (NEB). 
SCCmec did not integrate into this recipient chromosome (absence of left and right 
integrated chromosomal junctions). The only amplified products were the excised 
junction, circular SCCmec junction, mecA fragment, RN4220 specific ORF0042 
fragment, and the gene for mupirocin resistance.  In addition, an N315 specific product 
failed to amplify confirming that transconjugants were not donor contaminants.  The 
presence of mecA and mupirocin implied conjugative transfer. 
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recipient chromosome.  Instead, Figure 20 shows that the only amplified products were 
the excised junction, circular SCCmec junction, mecA, RN4220 specific ORF, and 
mupirocin.  In addition, an N315 specific product failed to amplify confirming that 
transconjugants were not donor contaminants.   
 When RN4220 pCN36 was the recipient, SCCmec did not integrate into the 
chromosome and the captured element remained on the conjugative plasmid under 
antibiotic selective pressure.  It has been reported and previously stated that the 
sequences surrounding the attB sites vary and can be important for SCCmec CcrAB-
mediated integration (86).  Figure 21 compares the attB sites of N315EX and RN4220.  
There are three SNPs present within 100 bp upstream of attB core sequence 
TATCATAA, and perhaps these may play a role in CcrAB recognition for integration.  It 
would be interesting to replace the SNPs with those in N315 to see if integration would 
be able to occur.  However, because there was no integration the captured population was 
enriched and these results, again, confirm that the SCCmec element is captured on 
pGO400 because the mecA and mupirocin probes co-migrate at 64 kb in comparison to 
the control of mupirocin alone at 34 kb.  In addition, whole genome sequencing of the 
strain RN4220 pCN36 pRM27 confirmed there is no SCCmec integration in the 
chromosome and that the SCCmec is captured on the conjugative plasmid via IS-
mediated recombination in this strain (Figure 22).  It would be interesting to see if the 
SCCmec element would recombine out from pGO400 and be lost without antibiotic 
pressure.  That would show that unless incoming SCCmec can integrate into the host 
chromosome immediately, the captured recombinant is transient and would thus explain 
why SCCmec has never been found on a conjugative plasmid before. 
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Figure 21.  Alignment of attB DNA regions in RN4220 and N315EX 
The alignment was done using ClustalW2 and results show that three SNPs were present 
in the 100bp region upstream of attB in the RN4220 site compared to N315.  The attB 
8bp core is highlighted in blue and the SNPs are highlighted in green.  
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Figure 22.  Map of pRM27 determined by whole genome sequencing 
 
MR14 SCCmec recombined with pGO400 via IS-mediated recombination. 
 
The assembly was made using the HGAP2 algorithm provided in the PacBio's 
SMRTportal package (version 2.3.0) at UNC Pacific Biosciences High Throughput 
Sequencing Facility.  The image was made using Geneious6 software.  
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These results are significant because they demonstrate the first time SCCmec has 
been captured on a conjugative plasmid capable of mobilization.  The results highlight 
the importance of IS elements in plasmid evolution and their ability to serve as a model 
for the mobility of resistance elements such as SCCmec among staphylococci.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
	   88	  
 
 
 
 
CHAPTER 6 
 
 
Results: 
 
Mobilization of captured SCCmec via conjugation 
 
After the capture of SCCmec on the conjugative plasmid pGO400, it was 
important to characterize the mobilization of pRM27 into various heterologous 
methicillin-sensitive recipients.   As previously mentioned, staphylococcal conjugative 
transfer frequencies are usually in the range of 10-5 to 10-6 per donor cell and can vary 
depending on the mating-pair genotypes (126).  In addition, the presence of mecA can 
serve has a host barrier as discussed before (125).  Therefore, it was important to first 
determine the baseline conjugative transfer frequencies of empty vector pGO400 into 
various recipients.  The donor in these conjugation experiments was RN4220 pCN36 
pGO400.  MSSA recipients as well as methicillin-sensitive S. aureus (MSSE) VCU113 
were passaged to become resistant to rifampin and novobiocin.  The endogenous 
erythromycin resistant phenotype was used for MSSE VCU129.  Donor strains were 
confirmed to be sensitive to the antibiotics to which the recipients were resistant.  As 
mentioned previously, Tn554 (encoding erythromycin resistance) in N315 SCCmec type 
II had been deleted in MR14.  Table 4 summarizes the methicillin-sensitive recipient 
hosts used and their respective pGO400 conjugative transfer frequencies.  The 
conjugative frequencies of empty vector pGO400 ranged from 10-5 to 10-7.   
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Baseline conjugation frequencies of pGO400 
into various recipients 
 
 
Table 4.  Conjugation frequencies of pGO400 ranged from 10-5 to 10-7.  Conjugation 
frequencies are expressed as the number of transconjugants divided by the number of 
donors.  Sa = S. aureus; Se = S. epidermidis; CC = clonal complex; NC = not classified.  
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Since pGO400 could be transferred into the chosen recipients, the mobilization of 
pRM27 into the same recipients was next assessed. The donor strain for these conjugative 
filter matings was RN4220 pCN36 pRM27 since Southern blot and PCR analyses 
confirmed that the SCCmec population was solely on the captured conjugative plasmid.  
This would increase the chance of mobilization because there was no competition for 
SCCmec re-integrating in the chromosome of the donor and thus decreasing the 
population of captured replicons.  Table 5 summarizes the conjugation frequencies of 
pRM27 into each recipient.  These data show a striking difference to the results obtained 
with pGO400, with transconjugants obtained at a much lower frequency or in some cases 
not at all.  In addition, when incubated on agar plates containing oxacillin, each recipient 
grew - indicating the presence of mecA - but all were heterotypic for oxacillin resistance.  
One very important result was the ability of pRM27 to mate into a S. epidermidis 
strain (VCU129).  Confirmation that the recipient was indeed S. epidermidis was done by 
plating donor, recipient, and transconjugant on phenol red mannitol salt agar (Figure 23) 
and also by performing PCR analysis for mecA and a S. epidermidis specific marker, 
arcC (Figure 24).  The high salt concentraion in this medium selects for staphylococci, 
and if a species can utilize mannitol as a carbon source then an acidic byproduct is 
formed that will change the pH of the medium and cause the phenol red in the agar to 
turn yellow.  S. aureus can utilize mannitol and therefore growth of the donor causes the 
agar to turn yellow as expected.  S. epidermidis cannot utilize mannitol, and the recipient 
and transconjuants grown on this agar did not result in a color change, confirming that 
they were S. epidermidis.  PCR results confirmed that mecA was detected in the donor 
and transconjugant but not in the recipient before mating, and the donor was negative for  
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Conjugation frequencies of pRM27 
into various recipients 
 
 
Table 5. Conjugation frequencies of pRM27, when detected, ranged from 10-7 to 10-10.  
Conjugation frequencies are expressed as the number of transconjugants divided by the 
number of donors.  Sa = S. aureus; Se = S. epidermidis; CC = clonal complex; NC = not 
classified 
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Figure 23.  Confirmation that the VCU129 recipient of pRM27 is S. epidermidis by 
plating on phenol red mannitol salt agar 
 
Confirmation that the recipient was indeed S. epidermidis was done by plating donor, 
recipient, and transconjugant on phenol red mannitol salt agar. Plates are initially red 
without bacterial growth. The high salt concentraion in this medium selects for 
staphylococci, and if a species can utilize mannitol as a carbon source then an acidic 
byproduct is formed that will change the pH of the medium and cause the phenol red in 
the agar to turn yellow.  S. aureus can utilize mannitol and growth of the donor causes the 
agar to turn yellow.  S. epidermidis cannot utilize mannitol, and the recipient and 
transconjuants grown on this agar did not result in a color change confirming they were S. 
epidermidis.    
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Figure 24.  PCR analysis to confirm S. epidermidis pRM27 transconjugants 
Six S. epidermidis transconjugants were confirmed by PCR analysis. 
Lane A. 1 kb ladder (NEB); Lanes 1-6. S. epidermidis transconjugants; Lane 7. RN4220 
pCN36 pRM27 donor control; Lane 8. S. epidermidis VCU129 recipient control. 
The left panel is PCR performed using mecA primers specfic to the donor alone and 
confirming that S. epidermidis transconjugants had aquired mecA because the S. 
epidermidis VCU129 recipient is negative for mecA prior to mating.   
The right panel is PCR performed using arcC S. epidermidis specific primers. All 
transconjugants were confirmed to be S. epidermidis as the tested positive for the 
presence of arcC. The donor RN4220 pCN36 pRM27 was negative for arcC and the 
recipient S. epidermidis VCU129 was positive for arcC as expected. 
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a S. epidermidis specific gene product while the recipient and transconjugants were 
positive.  These results confirm a mechanism of cross-species transfer of SCCmec that is 
known to have happened from epidemiological dataa but never been shown in the 
laboratory.  Equally important, VCU129 pRM27 was able to mate pRM27 back into S. 
aureus.  Plasmid pRM27 from VCU129 mated into RN4220 RifR NovR at a conjugation 
frequency of 1.96x10-6 and into MR14EX RifR NovR at a conjugation frequency of 
2.86x10-7.  This is significant because it is believed that CoNS species may be the origin 
of SCCmec, as discussed previously (34, 111).  It would be interesting to test for 
integration in each recipient discussed above as well as to compare more attB sites and 
test other MSSA/MSSE strains as potential recipients, to further classify the ability and 
restrictions of SCCmec mobilization and chromosomal integration.  
Results shown here and in Chapter 5 demonstrate that SCCmec can be captured 
on a conjugative plasmid and can be transferred consecutively into various heterologous 
S. aureus hosts as well as into S. epidermidis and back into S. aureus.  This shows for the 
first time that conjugative transfer is a probable mechanism of SCCmec transfer in nature.   
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CHAPTER 7 
 
Discussion 
 
 
SCCmec elements are designated as genomic islands.  Genomic islands are 
mobile DNA elements that are able to undergo horizontal gene transfer (HGT) by 
excision, transfer, and integration into a new cell.  Horizontal transfer of SCCmec into 
different S. aureus lineages has played a significant role in the evolution of MRSA. 
However, a well-characterized mechanism by which SCCmec moves among different 
strains and species of staphylococci has never been demonstrated until now. 
Horizontal gene transfer can occur via transformation, transduction, and/or 
conjugation.  One obvious potential means for horizontal transfer of SCCmec is via 
generalized transduction.  This study shows that phage 80α transduces SCCmec type I 
into a recipient, followed by SCCmec integration into the chromosome via homologous 
recombination.  SCCmec type I is 34.3 kb in size and is well within the range of 
chromosomal fragments that can be packaged by bacteriophage 80α which has a genome 
size of 43.9 kb.  Based on these findings and other published work discussed previously, 
MRSA strains that carry smaller SCCmec types (types I and IV) are more likely to be 
packaged and transferred by the known staphylococcal transducing phages that have a 
genome size around 40 kb.  This transduction mechanism, however, does not explain how 
the larger SCCmec elements may be transduced followed by att site-specific integration. 
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It is, however, possible that larger SCCmec elements can be packaged and 
transferred via other staphylococcal phages.  S. aureus phage genomes range in size from 
less than 20 kb to 140 kb (167, 168).  The largest characterized S. aureus phages belong 
to the Twort-like family, but they do not transduce foreign DNA and are, thus, not 
considered as a possible vehicle for SCCmec transfer (169).  Another potential 
mechanism for SCCmec transfer involves the induction of S. aureus prophages.  All S. 
aureus genomes sequenced to date contain at least one prophage, and many strains carry 
up to four (168).  Prophage induction and HGT have been extensively studied and are 
important mechanisms for transfer of staphylococcal virulence genes.  Specifically, 
prophage induction can be triggered by antibiotics and oxygen radicals (170).  Also, there 
have been many findings of bacteriophage transfer between S. aureus isolates during 
colonization and infection (171-174).  Therefore, it is possible that SCCmec could be 
packaged and transferred following prophage induction and, thus, could likely explain a 
mechanism of the spread of SCCmec among MRSA clinical isolates during infection.  
Based on sequence analysis, most of the S. aureus prophages are around 40 kb in size, so 
transfer of all SCCmec elements this way would be limited.  Recently, however, a large 
127.2 kb staphylococcal prophage was discovered in S. aureus strain TW20 that can 
transfer to few S. aureus strains (175).  As discussed previously, this prophage is 
extremely rare as it is only found in a few S. aureus isolates and, therefore, cannot 
explain an overall mechanism for SCCmec transfer among different lineages and across 
species. However, this finding highlights the possibility that larger SCCmec elements 
may be packaged and transferred via phages that have yet to be isolated and 
characterized. 
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Another important characteristic when considering transduction as a means for 
SCCmec transfer among lineages and species is phage host range.  As discussed 
previously, staphylococcal phages have been shown to participate in interspecies HGT 
(138, 176-179).  In addition, the host range of staphylococcal phages is much wider than 
previously believed, if just the ability to adsorb and inject DNA is considered.  Therefore, 
it is possible that the frequency of SCCmec transfer via phage in nature is higher than 
what was observed under laboratory conditions presented in this work.  
The generalized transduction of SCCmec observed in this study involved 
subsequent SCCmec integration via homologous recombination in an ideal recipient 
background.  Importantly, all MRSA strains sequenced to date show SCCmec integrated 
site-specifically via an att site within orfX, and S. aureus strains vary in the region 
downstream of orfX.  Therefore, homologous recombination alone cannot explain the 
acquisition of SCCmec in different lineages and among other species.  As mentioned 
previously, what is interesting in these studies is that the excised circular SCCmec 
junction had been packaged by the phage.  This is intriguing because upon transfer of the 
circular element integration could then occur via the specific att sites and, thus, warrants 
further investigation as previously described.  In addition, based on the findings by 
Maiques et al. with SaPIbov2 transfer, it is possible that linear SCCmec chromosomal 
fragments could be transduced into a recipient followed by ccrAB-mediated excision, 
circularization, and integration into the attB site of the recipient (177).  Because SCCmec 
excision was induced in the donor strain preceding transduction in this work, there would 
be fewer integrated chromosomal SCCmec elements within the population.  It would be 
interesting to perform transduction experiments without inducing SCCmec excision in 
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order to increase the transducing frequency of linear chromosomal fragments and then 
test if any transductants had acquired SCCmec via att site-specific integration in this 
regard.  However, this mechanism would not explain subsequent mobility and att site-
specific integration of SCCmec as many elements have truncations or deletions within 
their ccr complexes making the recombinases nonfunctional.  Therefore, perhaps in some 
instances regarding certain SCCmec types and specific lineages, generalized transduction 
followed by homologous recombination in the recipient is a likely means for SCCmec 
transfer among S. aureus strains in nature.  
Conjugation is a highly attractive alternative for transfer of SCCmec.  
Staphylococcal conjugative plasmids have a broad host range and can transfer among 
staphylococci via a mechanism similar to the ubiquitous Gram-negative conjugative 
plasmids (143-145).  As discussed previously, the existence of multiple staphylococcal 
conjugative plasmid derivatives showed that segments of DNA containing either entire 
integrated plasmids or antimicrobial resistance genes could be acquired via IS-mediated 
recombination (152, 159, 164).  This IS-mediated capture suggests a potential mechanism 
for the mobility of any genomic island containing a homologous IS element.  The 
sequencing of numerous bacterial strains has revealed a huge diversity of genomic 
islands, suggesting that any which contain an IS element could be captured on a 
conjugative plasmid this way.  Specifically, because all SCCmec elements contain an 
IS431 element, this mechanism seems highly favorable for SCCmec transfer. 
Indeed, these studies show, for the first time, the capture of a circular 30.8 kb 
SCCmec element on the conjugative plasmid pGO400.  Following capture of the 
SCCmec element on the conjugative plasmid transfer to both MSSA and MSSE recipients 
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was confirmed.  As mentioned previously, it is believed that S. aureus acquired SCCmec 
from coagulase-negative staphylococci.  Therefore, these studies are extremely important 
because, as never before been demonstrated, they define a mechanism of SCCmec 
transfer between S. aureus and S. epidermidis that likely represents transmission in the 
environment.  
Upon transfer into the MSSA recipients, data show integration of SCCmec in an 
isogenic recipient chromosome (N315EX) while no integration was detected in the 
heterologous recipient (RN4220 pCN36).  In addition to the expected integration into the 
chromosome of an isogenic recipient, it was observed that SCCmec had integrated as 
concatemers.  These multiple tandem copies of SCCmec highlight the importance of 
multiple integrations at the attL site that is characteristic of clinical isolates discussed 
previously, and may also explain the rearrangements seen in novel SCCmec types.  On 
the other hand, integration was not seen in the recipient RN4220.   As mentioned, 
comparison of the attB sites in N315EX and RN4220 by sequence alignment confirmed 
the presence of three SNPs 100bp upstream of attB.  Previous studies have shown this 
region to be important for CcrAB recognition and site-specific integration of SCCmec 
(86).  The difference in upstream sequence may account for failure of the SCCmec to 
integrate in RN4220.  This result may explain why certain lineages of S. aureus have not 
acquired SCCmec, and could lead to potential new avenues of investigation about the role 
of site-specific recognition sequences in SCCmec integration by CcrAB. 
Overall, it is suggested that SCCmec elements have been independently acquired 
several times through HGT, and transduction and conjugation are described as 
mechanisms of SCCmec transfer in this work.  Transduction results were only able to 
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show SCCmec transfer via generalized transduction followed by homologous 
recombination, and thus the results obtained under laboratory conditions are limited for 
describing a detailed mechanism of SCCmec transfer.  However, given the importance 
and variation of transduction in S. aureus HGT, other transduction mechanisms discussed 
above warrant further investigation, and it is believed that transduction of SCCmec 
occurs in nature under ideal conditions.  The data from conjugation experiments, 
however, characterize a specific, detailed mechanism of SCCmec transfer that is likely to 
occur readily in nature.  Importantly, SCCmec can be captured on a conjugative plasmid 
via IS-mediated recombination that can then be transferred into S. epidermidis followed 
by subsequent transfer back into S. aureus.  This strengthens the argument for 
conjugation as an important mechanism for SCCmec transfer.  The demonstration of 
cross-species transfer offers an explanation to previous data suggesting that coagulase-
negative staphylococci serve as the reservoir of SCCmec for S. aureus.  Therefore, these 
data describe, for the first time, a detailed mechanism for the environmental 
dissemination of methicillin resistance in nature.  This knowledge can provide important 
insight into SCCmec HGT as well as a means for understanding the emergence and 
persistence of SCCmec in both present and future MRSA isolates.  
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